GoPro (GPRO) 10-Q7 Nov 242024 Q3 Quarterly reportFinancial data

Company Profile

Cover

Cover - USD ($) $ in Thousands	9 Months Ended
Cover - USD ($) $ in Thousands	Sep. 30, 2024	Nov. 04, 2024	Jun. 30, 2023
Class of Stock [Line Items]
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	77-0629474
Entity Address, Address Line One	3025 Clearview Way
Entity Address, City or Town	San Mateo,
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94402
Title of 12(b) Security	Class A common stock, $0.0001 par value
Trading Symbol	GPRO
Entity Registrant Name	GOPRO, INC.
City Area Code	(650)
Local Phone Number	332-7600
Entity Central Index Key	0001500435
Entity Filer Category	Accelerated Filer
Document Type	10-Q
Document Period End Date	Sep. 30, 2024
Document Transition Report	false
Entity File Number	001-36514
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q3
Amendment Flag	false
Entity Emerging Growth Company	false
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Shell Company	false
Security Exchange Name	NASDAQ
Entity Small Business	false
Entity Public Float			$ 522,125
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	No
Document Quarterly Report	true
Common Class A [Member]
Class of Stock [Line Items]
Entity Common Stock, Shares Outstanding		128,502,519
Common Class B [Member]
Class of Stock [Line Items]
Entity Common Stock, Shares Outstanding		26,258,546

Audit Information

Audit Information - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
Audit Information - USD ($) $ in Thousands	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Audit Information [Abstract]
Revenues	$ 258,898	$ 294,299	$ 600,591	$ 710,039

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Preferred Stock, par value (usd per share)	$ 0.0001	$ 0.0001
Preferred Stock, Shares Authorized (shares)	5,000,000	5,000,000
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Treasury Stock, Value	$ 193,231,000	$ 193,231,000
Common Stocks, Including Additional Paid in Capital	1,021,590,000	998,373,000
Preferred Stock, Value, Outstanding	$ 0	$ 0
Treasury Stock, Common, Shares	26,608,000	26,608,000
Cash and cash equivalents	$ 130,195,000	$ 222,708,000
Marketable securities	0	23,867,000
Accounts receivable, net	133,161,000	91,452,000
Inventory	155,259,000	106,266,000
Prepaid expenses and other current assets	35,964,000	38,298,000
Property and equipment, net	8,798,000	8,686,000
Operating Lease, Right-of-Use Asset	15,738,000	18,729,000
Goodwill	152,351,000	146,459,000
Other long-term assets	30,137,000	311,486,000
Accounts payable	155,387,000	102,612,000
Accrued expenses and other current liabilities	124,299,000	110,049,000
Short-term operating lease liabilities	10,737,000	10,520,000
Deferred revenue	54,002,000	55,913,000
Long-term taxes payable	14,628,000	11,199,000
Long-term debt	93,053,000	92,615,000
Long-term operating lease liabilities	21,475,000	25,527,000
Other long-term liabilities	4,079,000	3,670,000
Accumulated deficit	(644,416,000)	(249,296,000)
Current assets:
Cash and cash equivalents	130,195,000	222,708,000
Marketable securities	0	23,867,000
Accounts receivable, net	133,161,000	91,452,000
Inventory	155,259,000	106,266,000
Prepaid expenses and other current assets	35,964,000	38,298,000
Total current assets	454,579,000	482,591,000
Property and equipment, net	8,798,000	8,686,000
Operating Lease, Right-of-Use Asset	15,738,000	18,729,000
Goodwill	152,351,000	146,459,000
Other long-term assets	30,137,000	311,486,000
Total assets	661,603,000	967,951,000
Current liabilities:
Accounts payable	155,387,000	102,612,000
Accrued expenses and other current liabilities	124,299,000	110,049,000
Short-term operating lease liabilities	10,737,000	10,520,000
Deferred revenue	54,002,000	55,913,000
Total current liabilities	344,425,000	279,094,000
Long-term taxes payable	14,628,000	11,199,000
Long-term debt	93,053,000	92,615,000
Long-term operating lease liabilities	21,475,000	25,527,000
Other long-term liabilities	4,079,000	3,670,000
Total liabilities	477,660,000	412,105,000
Commitments, contingencies and guarantees
Stockholders’ equity:
Preferred Stock, Value, Outstanding	0	0
Common Stocks, Including Additional Paid in Capital	1,021,590,000	998,373,000
Treasury Stock, Value	(193,231,000)	(193,231,000)
Accumulated deficit	(644,416,000)	(249,296,000)
Total stockholders’ equity	183,943,000	555,846,000
Total liabilities and stockholders’ equity	$ 661,603,000	$ 967,951,000
Preferred Stock, par value (usd per share)	$ 0.0001	$ 0.0001
Preferred Stock, Shares Authorized (shares)	5,000,000	5,000,000
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Treasury Stock, Common, Shares	26,608,000	26,608,000
Common Class A [Member]
Common stock outstanding (shares)	128,502,000	123,638,000
Common Stock, Shares Authorized (shares)	500,000,000	500,000,000
Common Stock, Shares, Issued	128,502,000	123,638,000
Stockholders’ equity:
Common Stock, Shares Authorized (shares)	500,000,000	500,000,000
Common Stock, Shares, Issued	128,502,000	123,638,000
Common Class B [Member]
Common stock outstanding (shares)	26,259,000	26,259,000
Common Stock, Shares Authorized (shares)	150,000,000	150,000,000
Common Stock, Shares, Issued	26,259,000	26,259,000
Stockholders’ equity:
Common Stock, Shares Authorized (shares)	150,000,000	150,000,000
Common Stock, Shares, Issued	26,259,000	26,259,000

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Sep. 30, 2024	Dec. 31, 2023
Preferred Stock, par value (usd per share)	$ 0.0001	$ 0.0001
Preferred Stock, Shares Authorized (shares)	5,000,000	5,000,000
Preferred Stock, Shares Issued (shares)	0	0
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Treasury Stock, Common, Shares	26,608,000	26,608,000
Common Class A [Member]
Common Stock, Shares Authorized (shares)	500,000,000	500,000,000
Common Stock, Shares, Issued	128,502,000	123,638,000
Common stock outstanding (shares)	128,502,000	123,638,000
Common Class B [Member]
Common Stock, Shares Authorized (shares)	150,000,000	150,000,000
Common Stock, Shares, Issued	26,259,000	26,259,000
Common stock outstanding (shares)	26,259,000	26,259,000

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($) shares in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Income Statement [Abstract]
Revenues	$ 258,898,000	$ 294,299,000	$ 600,591,000	$ 710,039,000
Cost of revenue	167,052,000	200,095,000	398,997,000	487,561,000
Gross profit	91,846,000	94,204,000	201,594,000	222,478,000
Operating expenses:
Research and development	44,328,000	41,708,000	135,872,000	121,796,000
Sales and marketing	40,686,000	41,254,000	117,185,000	119,215,000
General and administrative	14,843,000	15,029,000	44,470,000	47,562,000
Total operating expenses	99,857,000	97,991,000	297,527,000	288,573,000
Operating loss	(8,011,000)	(3,787,000)	(95,933,000)	(66,095,000)
Interest expense	(808,000)	(1,171,000)	(2,272,000)	(3,463,000)
Other income, net	2,691,000	1,963,000	4,710,000	7,231,000
Total other income, net	1,883,000	792,000	2,438,000	3,768,000
Loss before income taxes	(6,128,000)	(2,995,000)	(93,495,000)	(62,327,000)
Income tax expense (benefit)	2,083,000	689,000	301,625,000	(11,562,000)
Net loss	$ (8,211,000)	$ (3,684,000)	$ (395,120,000)	$ (50,765,000)
Earnings Per Share, Basic	$ (0.05)	$ (0.02)	$ (2.59)	$ (0.33)
Earnings Per Share, Diluted	$ (0.05)	$ (0.02)	$ (2.59)	$ (0.33)
Weighted Average Number of Shares Outstanding, Basic	153,741	152,409	152,449	154,113
Weighted Average Number of Shares Outstanding, Diluted	153,741	152,409	152,449	154,113

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Cash Flows $ in Thousands	9 Months Ended
	Sep. 30, 2024 USD ($)	Sep. 30, 2023 USD ($)	Dec. 31, 2022 USD ($)
Operating activities:
Net loss	$ (395,120)	$ (50,765)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	4,711	5,001
operating lease, right-of-use asset, periodic reduction, net	(285)	2,133
Stock-based compensation	23,933	31,448
Deferred income taxes	296,759	(17,964)
Operating Lease, Impairment Loss	3,276	0
Other	(627)	(1,968)
Changes in operating assets and liabilities:
Accounts receivable, net	(41,746)	(30,630)
Inventory	(48,993)	(27,745)
Prepaid expenses and other assets	(4,650)	(6,895)
Accounts payable and other liabilities	64,807	25,712
Deferred revenue	(2,107)	(4,919)
Net Cash Provided by (Used in) Operating Activities	(100,042)	(76,592)
Investing activities:
Purchases of property and equipment, net	(3,623)	(985)
Purchases of marketable securities	0	(25,782)
Maturities of marketable securities	24,000	134,204
Payments for (Proceeds from) Other Investing Activities	12,308	0
Net cash provided by investing activities	8,069	107,437
Financing activities:
Proceeds from issuance of common stock	2,150	3,876
Payment, Tax Withholding, Share-based Payment Arrangement	(2,847)	(7,146)
Payments for Repurchase of Common Stock	0	(30,000)
Net cash used in financing activities	(697)	(33,270)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	157	(326)
Cash and cash equivalents	130,195	220,984
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$ (92,513)	$ (2,751)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents			$ 223,735

Condensed Consolidated Statem_3

Condensed Consolidated Statements Stockholders' Equity (Deficit) - USD ($) shares in Thousands, $ in Thousands	Total	Customer B [Member] Sales Revenue [Member] Customer Concentration Risk [Member]	Retained Earnings [Member]	Common Stock Including Additional Paid in Capital [Member]	Treasury Stock, Common
Stockholders' Equity Attributable to Parent	$ 611,559		$ (196,113)	$ 960,903	$ (153,231)
Shares, Outstanding				154,888
Allocated share-based compensation expense	10,314			$ 10,314
Stock Repurchased During Period, Value	(5,000)
Treasury Stock, Value, Acquired, Cost Method	$ (5,000)
Stock Repurchased During Period, Shares	(890)
Net loss	$ (29,869)		(29,869)
Common stock issued under employee benefit plans, net of shares withheld for tax	2,397			$ 2,397
Common stock issued under employee benefit plans, net of shares withheld for tax (shares)				1,960
Share-based Payment Arrangement, Decrease for Tax Withholding Obligation	(4,251)			$ 4,251
Payments for Repurchase of Common Stock	30,000
Stock Repurchased During Period, Value	(30,000)
Net loss	(50,765)
Concentration risk		10%
Stockholders' Equity Attributable to Parent	585,150		(225,982)	$ 969,363	(158,231)
Shares, Outstanding				155,958
Allocated share-based compensation expense	11,117			$ 11,117
Stock Repurchased During Period, Value	(15,000)
Treasury Stock, Value, Acquired, Cost Method	$ (15,000)
Stock Repurchased During Period, Shares	(3,606)
Net loss	$ (17,212)		(17,212)
Common stock issued under employee benefit plans, net of shares withheld for tax	7			$ 7
Common stock issued under employee benefit plans, net of shares withheld for tax (shares)				375
Share-based Payment Arrangement, Decrease for Tax Withholding Obligation	(583)			$ 583
Stockholders' Equity Attributable to Parent	563,479		(243,194)	$ 979,904	(173,231)
Shares, Outstanding				152,727
Allocated share-based compensation expense	10,017			$ 10,017
Stock Repurchased During Period, Value	(10,000)
Treasury Stock, Value, Acquired, Cost Method	$ (10,000)
Stock Repurchased During Period, Shares	(2,605)
Net loss	$ (3,684)		(3,684)
Common stock issued under employee benefit plans, net of shares withheld for tax	1,580			$ 1,580
Common stock issued under employee benefit plans, net of shares withheld for tax (shares)				1,918
Share-based Payment Arrangement, Decrease for Tax Withholding Obligation	(2,312)			$ 2,312
Stockholders' Equity Attributable to Parent	559,080		(246,878)	$ 989,189	(183,231)
Shares, Outstanding				152,040
Stockholders' Equity Attributable to Parent	555,846		(249,296)	$ 998,373	(193,231)
Shares, Outstanding				149,897
Allocated share-based compensation expense	8,770			$ 8,770
Net loss	(339,088)		(339,088)
Common stock issued under employee benefit plans, net of shares withheld for tax	1,361			$ 1,361
Common stock issued under employee benefit plans, net of shares withheld for tax (shares)				2,403
Share-based Payment Arrangement, Decrease for Tax Withholding Obligation	(1,977)			$ 1,977
Payments for Repurchase of Common Stock	0
Stock Repurchased During Period, Value	0
Net loss	(395,120)
Stockholders' Equity Attributable to Parent	224,912		(588,384)	$ 1,006,527	(193,231)
Shares, Outstanding				152,300
Allocated share-based compensation expense	7,791			$ 7,791
Net loss	(47,821)		(47,821)
Common stock issued under employee benefit plans, net of shares withheld for tax (shares)				430
Share-based Payment Arrangement, Decrease for Tax Withholding Obligation	(203)			$ 203
Stockholders' Equity Attributable to Parent	184,679		(636,205)	$ 1,014,115	(193,231)
Shares, Outstanding				152,730
Allocated share-based compensation expense	7,372			$ 7,372
Stock Repurchased During Period, Value	0
Net loss	(8,211)		(8,211)
Common stock issued under employee benefit plans, net of shares withheld for tax	770			$ 770
Common stock issued under employee benefit plans, net of shares withheld for tax (shares)				2,031
Share-based Payment Arrangement, Decrease for Tax Withholding Obligation	(667)			$ 667
Stockholders' Equity Attributable to Parent	$ 183,943		$ (644,416)	$ 1,021,590	$ (193,231)
Shares, Outstanding				154,761

Summary of business and signifi

Summary of business and significant accounting policies		9 Months Ended
Summary of business and significant accounting policies	Feb. 27, 2024	Sep. 30, 2024
Accounting Policies [Abstract]
Summary of business and significant accounting policies		GoPro, Inc. and its subsidiaries (GoPro or the Company) make it easy for the world to capture and share itself in immersive and exciting ways, helping people get the most out of their photos and videos. The Company is committed to developing solutions that create an easy, seamless experience for consumers to capture, create, manage and share engaging personal content. To date, the Company’s cameras, mountable and wearable accessories, subscription and service, and implied post contract support have generated substantially all of its revenue. The Company sells its products globally on its website, and through retailers and wholesale distributors. The Company’s global corporate headquarters are located in San Mateo, California. Basis of presentation. The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (GAAP) for financial information set forth in the Accounting Standards Codification (ASC), as published by the Financial Accounting Standards Board (FASB), and with the applicable rules and regulations of the Securities and Exchange Commission (SEC). The Company’s fiscal year ends on December 31, and its fiscal quarters end on March 31, June 30, and September 30. The condensed consolidated financial statements reflect all adjustments, which are normal and recurring in nature, that management believes are necessary for the fair statement of the Company's financial statements, but are not necessarily indicative of the results expected in future periods. The Condensed Consolidated Balance Sheet as of December 31, 2023 has been derived from the audited financial statements at that date, but does not include all the disclosures required by GAAP. This Quarterly Report on Form 10-Q should be read in conjunction with the Company's Annual Report on Form 10-K for the year ended December 31, 2023 (2023 Annual Report). There have been no material changes in the Company’s critical accounting policies and estimates from those disclosed in its 2023 Annual Report, except for estimates used in the Company’s goodwill impairment analysis and assessment of the recoverability of the Company’s deferred tax assets. Principles of consolidation. These condensed consolidated financial statements include all the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. Use of estimates. The preparation of condensed consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported and disclosed in the Company’s condensed consolidated financial statements and accompanying notes. Significant estimates and assumptions made by management include those related to revenue recognition and the allocation of the transaction price (including sales incentives, sales returns and implied post contract support), inventory valuation, product warranty liabilities, the valuation, impairment and useful lives of long-lived assets (property and equipment, operating lease right-of-use assets, intangible assets and goodwill), fair value of convertible senior notes, and income taxes. The Company bases its estimates and assumptions on historical experience and on various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ materially from management’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations could be affected. The Company performs an annual assessment of its goodwill during the fourth quarter of each calendar year or more frequently if indicators of potential impairment exist, such as an adverse change in business climate, declines in market capitalization or a decline in the overall industry demand, that would indicate it is more likely than not that the fair value of its single reporting unit is less than its’ carrying value. If the Company determines that it is more likely than not that the fair value of its single reporting unit is less than the carrying value, the Company measures the amount of impairment as the amount the carrying value of its single reporting unit exceeds the fair value, up to the carrying value of goodwill, by using a discounted cash flow method and market approach method. Although the Company’s market capitalization further declined in the third quarter of 2024, the Company does not believe that it is more likely than not that the fair value of its single reporting unit is less than the carrying value. Using the market capitalization approach, which the Company expects would be similar to the discounted cash flow method, the fair value of the single reporting unit is estimated based on the trading price of the Company’s stock at the test date, which is further adjusted by an acquisition control premium representing the synergies a market participant would obtain when obtaining control of the business. As of September 30, 2024, the market capitalization exceeded the carrying value of the single reporting unit by 13% which was not adjusted for an acquisition control premium. The acquisition control premium would further increase the percentage by which the estimated fair value of the Company’s single reporting unit would exceed the carrying value. The estimated fair value of the Company’s single reporting unit is sensitive to the volatility in the Company’s stock price. For example, a 5% decrease in the Company’s September 30, 2024 stock price would result in its market capitalization exceeding the carrying value of its single reporting unit by 8%, which is not adjusted for an acquisition control premium. If the Company's market capitalization continues to decline or future performance falls below the Company’s current expectations, assumptions, or estimates, including assumptions related to current macroeconomic uncertainties, this may trigger a future material non-cash goodwill impairment charge, which could have a material adverse effect on the Company’s business, financial condition, and results of operations in the reporting period in which a charge would be necessary. The Company will continue to monitor developments, including updates to the Company’s forecasts and market capitalization. An update of the Company’s assessment and related estimates may be required in the future. Liquidity. As of September 30, 2024, the Company had $130.2 million in cash, cash equivalents and marketable securities and an accumulated deficit of $644.4 million. Based on the Company’s current cash balance, its cost reductions implemented to date, and working capital adjustments, the Company anticipates it will have sufficient funds to meet its strategic and working capital requirements, debt service requirements and lease payment obligations for at least twelve months from the issuance of these condensed consolidated financial statements. The Company also had $44.8 million available to draw from its 2021 Credit Agreement (as defined below) as of September 30, 2024 and its 2025 Notes are due in November 2025, which the Company has the ability to convert the balance due into stock under certain circumstances. If the Company is unable to obtain adequate debt or equity financing when it is required or on terms acceptable to the Company, the Company’s ability to grow its business, repay debt and respond to business challenges could be significantly limited. Although management believes its current cash resources are sufficient to sustain operations for one year from issuance of these condensed consolidated financial statements, the success of the Company’s operations and the global economic outlook, among other factors, could impact its business and liquidity. The Company will continue to evaluate additional measures, including cost reduction initiatives, debt or equity refinancing, and other similar arrangements. In addition, in October 2024, the Company initiated a cost reduction effort that is expected to reduce headcount by approximately 26% compared to its headcount ending Q2 2024, reduce marketing expenses in the second half of 2024 as well as 2025, and reduce other general expenses. Management considered whether there are conditions or events that raise substantial doubt about the Company’s ability to continue as a going concern and evaluated the funds necessary to maintain operations. Based on the Company’s current cash flow projections, the Company has concluded that its available cash and cash equivalents are sufficient to continue operating activities for at least twelve months following the issuance date of these condensed consolidated financial statements. Comprehensive income (loss). For all periods presented, comprehensive income (loss) approximated net income (loss). Therefore, the Condensed Consolidated Statements of Comprehensive Income (Loss) have been omitted. Revenue recognition. The Company derives substantially all of its revenue from the sale of cameras, mounts, accessories, subscription and service, and implied post contract support to customers. The transaction price recognized as revenue represents the consideration the Company expects to be entitled to and is primarily comprised of product revenue, net of returns and variable consideration, which includes sales incentives provided to customers. The Company’s camera sales contain multiple performance obligations that can include the following four separate obligations: (i) a camera hardware component (which may be bundled with hardware accessories) and the embedded firmware essential to the functionality of the camera component delivered at the time of sale, (ii) a subscription and service, (iii) the implied right for the customer to receive post contract support after the initial sale (PCS), and (iv) the implicit right to the Company’s downloadable free apps and software solutions. The Company’s PCS includes the right to receive, on a when and if available basis, future unspecified firmware upgrades and features as well as bug fixes, and email, chat, and telephone support. The Company recognizes revenue from its sales arrangements when control of the promised goods or services are transferred to its customers, in an amount that reflects the amount of consideration expected to be received in exchange for the transferred goods or services. For the sale of hardware products, including related firmware and free software solutions, revenue is recognized when transfer of control occurs at a point in time, which generally is at the time the hardware product is shipped and collection is considered probable. For customers who purchase products directly from GoPro.com, the Company retains a portion of the risk of loss on these sales during transit, which are accounted for as fulfillment costs. For PCS, revenue is recognized ratably over 24 months, which represents the estimated period PCS is expected to be provided based on historical experience. The Company’s subscription and service revenue is recognized primarily from its Premium+, Premium, and Quik subscription offerings and is recognized ratably over the subscription term, with any payments received in advance of services rendered recorded as deferred revenue. The Company launched its Premium+ subscription in February 2024, which includes cloud storage up to 500 gigabytes (GB) of non-GoPro content, access to GoPro’s HyperSmooth Pro video stabilization software, and the features included in the Premium subscription. The Company’s Premium subscription offers a range of services, including unlimited cloud storage of GoPro content supporting source video and photo quality, damaged camera replacement, cloud storage up to 25 GB of non-GoPro content, highlight videos automatically delivered via the Company’s mobile app when GoPro camera footage is uploaded to a GoPro cloud account using Auto Upload, access to a high-quality live streaming service on GoPro.com as well as discounts on GoPro cameras, gear, mounts, and accessories. The Company also offers the Quik subscription that provides access to a suite of simple single-clip and multi-clip editing tools. Subscription and service revenue was $27.5 million, or 10.6% of total revenue for the three months ended September 30, 2024, and $79.7 million, or 13.3% of total revenue for the nine months ended September 30, 2024. Subscription and service revenue as a percentage of 2023 annual revenue was not material. For the Company’s camera sale arrangements with multiple performance obligations, revenue is allocated to each performance obligation based on its relative standalone selling price. Standalone selling prices are based on observable prices at which the Company separately sells its products, and subscription and service. If a standalone selling price is not directly observable, then the Company estimates the standalone selling prices considering market conditions and entity-specific factors. For example, the standalone selling price for PCS is determined based on a cost-plus approach, which incorporates the level of support provided to customers, estimated costs to provide such support, and the amount of time and costs that are allocated to efforts to develop the undelivered elements. The Company’s standard terms and conditions of sale for non-web-based sales do not allow for product returns other than under warranty. However, the Company grants limited rights of return, primarily to certain large retailers. The Company reduces revenue and cost of sales for the estimated returns based on analyses of historical return trends by customer class and other factors. An estimated return liability along with a right to recover assets are recorded for future product returns. Return trends are influenced by product life cycles, new product introductions, market acceptance of products, product sell-through, the type of customer, seasonality, and other factors. Return rates may fluctuate over time but are sufficiently predictable to allow the Company to estimate expected future product returns. The Company provides sales commissions to internal and external sales representatives which are earned in the period in which revenue is recognized. As a result, the Company expenses sales commissions as incurred. Deferred revenue as of September 30, 2024 and December 31, 2023, includes amounts related to the Company’s subscriptions and PCS. The Company’s short-term and long-term deferred revenue balances totaled $57.0 million and $59.1 million as of September 30, 2024 and December 31, 2023, respectively. Of the deferred revenue balance as of December 31, 2023 and 2022, the Company recognized $11.2 million and $12.2 million of revenue during the three months ended September 30, 2024 and 2023, respectively, and $50.6 million and $50.6 million of revenue during the nine months ended September 30, 2024 and 2023, respectively. Of the deferred revenue balance as of June 30, 2024 and 2023, the Company recognized $23.0 million and $23.1 million of revenue during the three months ended September 30, 2024 and 2023, respectively. Sales incentives. The Company offers sales incentives through various programs, including cooperative advertising, price protection, marketing development funds, and other incentives. Sales incentives are considered to be variable consideration, which the Company estimates and records as a reduction to revenue at the date of sale. The Company estimates sales incentives based on historical experience, product sell-through, and other factors. Income taxes. The Company utilizes the asset and liability method for computing its income tax provision, under which, deferred tax assets and liabilities are recognized for the expected future consequences of temporary differences between the financial reporting and tax bases of assets and liabilities using enacted tax rates. Management makes estimates, assumptions, and judgments to determine the Company’s provision for income taxes, deferred tax assets and liabilities, and any valuation allowance recorded against deferred tax assets. The Company assesses the likelihood that its deferred tax assets will be recovered from future taxable income in each tax jurisdiction and, to the extent the Company believes recovery is not likely, establishes a valuation allowance. In the first quarter of 2024, the Company provided a valuation allowance of $294.9 million on United States federal and state deferred tax assets. The Company intends to continue to maintain a full valuation allowance on its United States federal and state deferred tax assets until there is sufficient evidence to support the reversal of all or some portion of these allowances. The Company recognizes the tax benefit from an uncertain tax position only if it is more likely than not the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized from such positions are then measured based on the largest benefit that has a greater than 50% likelihood of being realized upon settlement. Interest and penalties related to unrecognized tax benefits are recognized within income tax expense. Segment information. The Company operates as one operating segment as it only reports financial information on an aggregate and consolidated basis to its Chief Executive Officer, who is the Company’s chief operating decision maker. Business Acquisitions. The Company accounts for acquired businesses using the acquisition method of accounting, which requires that once control of a business is obtained, 100% of the assets acquired and liabilities assumed be recorded at the date of acquisition at their respective fair values. Any excess of the purchase price over the estimated fair values of the net assets acquired is recorded as goodwill. Acquisition-related expenses including transaction and integration costs are expensed as incurred. The Company uses various models to determine the value of assets acquired such as the cost method. Determining the useful life of an intangible asset also requires judgment as different types of intangible assets will have different useful lives and certain assets may be considered to have indefinite useful lives. Recent accounting standards. Standard Description Effect on the condensed consolidated financial statements or other significant matters Standards not yet adopted Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures ASU No. 2023-07 This standard is intended to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses on an interim and annual basis. Additionally, this standard would require that a public entity that has a single reportable segment provide all the disclosures required by the standard and all existing segment disclosures in Topic 280. This standard is effective for fiscal years beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The standard requires retrospective application. The Company is currently evaluating the impact of adopting this standard on its 2024 Form 10-K financial statements and related disclosures. Income Taxes (Topic 740): Improvements to Income Tax Disclosures ASU No. 2023-09 This standard requires reporting companies to break out income tax expense and a tax rate reconciliation in more detail. This standard is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The standard requires prospective transition with the option to apply retrospectively. The Company is currently evaluating the impact of adopting this standard on its financial statements and related disclosures. Although there are several other new accounting standards issued or proposed by the FASB, which the Company has adopted or will adopt, as applicable, the Company does not believe any of these accounting pronouncements has had or will have a material impact on its condensed consolidated financial statements.
Accounting Standards Update and Change in Accounting Principle		Recent accounting standards. Standard Description Effect on the condensed consolidated financial statements or other significant matters Standards not yet adopted Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures ASU No. 2023-07 This standard is intended to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses on an interim and annual basis. Additionally, this standard would require that a public entity that has a single reportable segment provide all the disclosures required by the standard and all existing segment disclosures in Topic 280. This standard is effective for fiscal years beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The standard requires retrospective application. The Company is currently evaluating the impact of adopting this standard on its 2024 Form 10-K financial statements and related disclosures. Income Taxes (Topic 740): Improvements to Income Tax Disclosures ASU No. 2023-09 This standard requires reporting companies to break out income tax expense and a tax rate reconciliation in more detail. This standard is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The standard requires prospective transition with the option to apply retrospectively. The Company is currently evaluating the impact of adopting this standard on its financial statements and related disclosures. Although there are several other new accounting standards issued or proposed by the FASB, which the Company has adopted or will adopt, as applicable, the Company does not believe any of these accounting pronouncements has had or will have a material impact on its condensed consolidated financial statements.
Business acquisitions	, the Company completed an acquisition of Forcite Helmet Systems, a privately-held company that offers technology-enabled helmets, for total consideration of $14.0 million. The allocation of the purchase price primarily included $7.5 million in developed technology and $5.9 million of residual goodwill. Net tangible assets acquired were not material. Goodwill is primarily attributable to expected synergies in the technologies that can be leveraged by the Company in future product offerings. The operating results of the acquired entity have been included in the Company’s condensed consolidated financial statements from the date of acquisition. Actual and pro forma results of operations for this acquisition have not been presented because they did not have a material impact to the Company’s condensed consolidated results of operations.

Business Acquisitions

Business Acquisitions	Feb. 27, 2024
Business Combinations [Abstract]
Business acquisitions	, the Company completed an acquisition of Forcite Helmet Systems, a privately-held company that offers technology-enabled helmets, for total consideration of $14.0 million. The allocation of the purchase price primarily included $7.5 million in developed technology and $5.9 million of residual goodwill. Net tangible assets acquired were not material. Goodwill is primarily attributable to expected synergies in the technologies that can be leveraged by the Company in future product offerings. The operating results of the acquired entity have been included in the Company’s condensed consolidated financial statements from the date of acquisition. Actual and pro forma results of operations for this acquisition have not been presented because they did not have a material impact to the Company’s condensed consolidated results of operations.

Fair value measurements

Fair value measurements	9 Months Ended
Fair value measurements	Sep. 30, 2024
Fair Value Disclosures [Abstract]
Fair Value measurements	Fair value measurements The Company’s assets that are measured at fair value on a recurring basis within the fair value hierarchy are summarized as follows: September 30, 2024 December 31, 2023 (in thousands) Level 1 Level 2 Total Level 1 Level 2 Total Cash equivalents (1) : Money market funds $ 60,344 $ — $ 60,344 $ 152,760 $ — $ 152,760 Total cash equivalents $ 60,344 $ — $ 60,344 $ 152,760 $ — $ 152,760 Marketable securities: U.S. treasury securities $ — $ — $ — $ — $ 7,962 $ 7,962 Commercial paper — — — — 7,942 7,942 Corporate debt securities — — — — 3,978 3,978 Government securities — — — — 3,985 3,985 Total marketable securities $ — $ — $ — $ — $ 23,867 $ 23,867 (1) Included in cash and cash equivalents in the accompanying Condensed Consolidated Balance Sheets. Cash balances were $69.9 million and $69.9 million as of September 30, 2024 and December 31, 2023, respectively. Cash equivalents are classified as Level 1 because the Company uses quoted market prices to determine their fair value. Marketable securities are classified as Level 2 because the Company uses alternative pricing sources and models utilizing market observable inputs to determine their fair value. The Company held no marketable securities as of September 30, 2024, and the contractual maturities of available-for-sale marketable securities as of December 31, 2023 were all less than one year in duration. As of September 30, 2024 and December 31, 2023, the Company had no financial assets or liabilities measured at fair value on a recurring basis that were classified as Level 3, which are valued based on inputs supported by little or no market activity. As of September 30, 2024 and December 31, 2023, the amortized cost of the Company’s cash equivalents and marketable securities approximated their fair value and there were no material realized or unrealized gains or losses, either individually or in the aggregate. In November 2020, the Company issued $143.8 million principal amount of Convertible Senior Notes due 2025 (2025 Notes) (see Note 5 Financing arrangements). In November 2023, the Company repurchased $50.0 million in aggregate principal amount of the 2025 Notes. The calculated fair value of the 2025 Notes was $82.5 million and $82.3 million as of September 30, 2024 and December 31, 2023, respectively. The estimated fair value of the 2025 Notes is based on quoted market prices of the Company’s instruments in markets that are not active and are classified as Level 2 within the fair value hierarchy. The Company estimated the fair value of the 2025 Notes by evaluating quoted market prices and calculating the upfront cash payment a market participant would require to assume these obligations. Equity securities without readily identifiable fair values include the Company’s investments in privately-held companies consisting of preferred stock. The Company accounts for these securities at cost, adjusted for changes from observable transactions for identical or similar investments of the same issuer, less impairments. Fair value of these equity securities is reassessed when the Company identifies observable price changes indicating that an adjustment to the carrying value is necessary. Any observable changes in fair value are recognized in earnings as of the date that the observable transaction took place. In addition, the Company periodically evaluates equity securities without readily determinable fair values to determine if impairment charges are required by evaluating whether an event or change in circumstance has occurred that may have a significant adverse effect on the fair value of the investment. A qualitative assessment is performed each reporting period to assess whether there are any impairment indicators, including, but not limited to, significant deterioration in the investee's earnings performance, credit rating, asset quality or business prospects, adverse change in the regulatory, economic, or technological environment, change in the general market condition of the geographic area or industry, acquisition offers, and the ability to continue as a going concern. If such indicators are present, the Company estimates the fair value of impaired investments and recognizes an impairment loss in the Condensed Consolidated Statements of Operations equal to the difference between the carrying value and fair value. As of September 30, 2024 and December 31, 2023, the carrying value of the Company’s equity investments without readily determinable fair values was $1.0 million and zero, which was recorded as a component of other long-term assets. The Company’s investments in equity without readily determinable fair value are classified as Level 3 asset due to the lack of observable inputs to determine fair value. For the three and nine months ended September 30, 2024 and 2023, there have been no impairments or downward or upward adjustments for equity securities without readily determinable fair values. For certain other financial assets and liabilities, including accounts receivable, accounts payable and other current assets and liabilities, the carrying amounts approximate their fair value primarily due to the relatively short maturity of these balances. The Company also measures certain non-financial assets at fair value on a nonrecurring basis, primarily goodwill, intangible assets, and operating lease right-of-use assets, in connection with periodic evaluations for potential impairment.

Condensed consolidated financia

Condensed consolidated financial statement details	9 Months Ended
Condensed consolidated financial statement details	Sep. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Intangible Assets Disclosure	Intangible assets Useful life September 30, 2024 (in thousands) Gross carrying value Accumulated amortization Net carrying value Purchased technology 20-72 $ 58,566 $ (52,160) $ 6,406 Domain name 15 — 15 Total intangible assets $ 58,581 $ (52,160) $ 6,421 Useful life December 31, 2023 (in thousands) Gross carrying value Accumulated amortization Net carrying value Purchased technology 20-72 $ 51,066 $ (51,066) $ — Domain name 15 — 15 Total intangible assets $ 51,081 $ (51,066) $ 15 The gross carrying value of purchased technology increased $7.5 million from December 31, 2023 as a result of the acquisition of Forcite Helmet Systems in February 2024 (see Note 2 Business Acquisitions). Amortization expense was $0.5 million and zero for the three months ended September 30, 2024 and 2023, respectively, and $1.1 million and zero for the nine months ended September 30, 2024 and 2023, respectively. As of September 30, 2024, expected amortization expense of intangible assets with definite lives for future periods was as follows: (in thousands) Total Year ending December 31, 2024 (remaining 3 months) $ 468 2025 1,875 2026 1,875 2027 1,875 2028 313 $ 6,406

Financing Arrangements

Financing Arrangements	9 Months Ended
Financing Arrangements	Sep. 30, 2024
Debt Disclosure [Abstract]
Financing Arrangements	5. Financing arrangements 2021 Credit Facility In January 2021, the Company entered into a Credit Agreement which provides for a revolving credit facility (2021 Credit Facility) under which the Company may borrow up to an aggregate amount of $50.0 million. In March 2023, the Company amended the 2021 Credit Agreement (collectively, the 2021 Credit Agreement). The 2021 Credit Agreement will terminate and any outstanding borrowings become due and payable on the earlier of (i) January 2027 and (ii) unless the Company has cash in a specified deposit account in an amount equal to or greater than the amount required to repay the Company’s 1.25% Convertible Senior Notes due November 2025, 91 days prior to the maturity date of such convertible notes. The amount that may be borrowed under the 2021 Credit Agreement may be based on a customary borrowing base calculation if the Company’s Asset Coverage Ratio is at any time less than 1.50. The Asset Coverage Ratio is defined as the ratio of (i) the sum of (a) the Company’s cash and cash equivalents in the United States plus specified percentages of other qualified debt investments (Qualified Cash) plus (b) specified percentages of the net book values of the Company’s accounts receivable and certain inventory to (ii) $50.0 million. Borrowed funds accrue interest at the greater of (i) a per annum rate equal to the base rate plus a margin of from 0.50% to 1.00% depending on the Company’s Asset Coverage Ratio or (ii) a per annum rate equal to the Secured Overnight Financing Rate plus a 10 basis point premium and a margin of from 1.50% to 2.00% depending on the Company’s Asset Coverage Ratio. The Company is required to pay a commitment fee on the unused portion of the 2021 Credit Facility of 0.25% per annum. Amounts owed under the 2021 Credit Agreement are guaranteed by certain of the Company’s United States subsidiaries and secured by a first priority security interest in substantially all of the assets of the Company and certain of its subsidiaries (other than intellectual property, which is subject to a negative pledge restricting grants of security interests to third parties). The 2021 Credit Agreement contains customary representations, warranties, and affirmative and negative covenants. The negative covenants include restrictions on the incurrence of liens and indebtedness, certain investments, dividends, stock repurchases, and other matters, all subject to certain exceptions. In addition, the Company is required to maintain Liquidity (the sum of unused availability under the credit facility and the Company’s Qualified Cash) of at least $55.0 million (of which at least $40.0 million shall be attributable to Qualified Cash), or, if the borrowing base is then in effect, minimum unused availability under the credit facility of at least $10.0 million. The 2021 Credit Agreement also includes customary events of default that include, among other things, non-payment of principal, interest or fees, inaccuracy of representations and warranties, violation of certain covenants, cross default to certain other indebtedness, bankruptcy and insolvency events, material judgments and change of control. Upon an event of default, the lender may, subject to customary cure rights, require the immediate payment of all amounts outstanding. As of September 30, 2024, the Company was in compliance with all financial covenants contained in the 2021 Credit Agreement and has made no borrowings from the 2021 Credit Facility to date. There is an outstanding letter of credit under the 2021 Credit Agreement of $5.2 million for certain duty-related requirements which was not collateralized by any cash on hand. As of September 30, 2024, the Company could borrow up to $44.8 million under the 2021 Credit Agreement. 2025 Convertible Notes In November 2020, the Company issued $125.0 million aggregate principal amount of 1.25% Convertible Senior Notes due 2025 (the 2025 Notes) and granted an option to the initial purchasers to purchase up to an additional $18.8 million aggregate principal amount of the 2025 Notes to cover over-allotments, of which $18.8 million was subsequently exercised during November 2020, resulting in a total issuance of $143.8 million aggregate principal amount of the 2025 Notes. The 2025 Notes are senior, unsecured obligations of the Company and mature on November 15, 2025, unless earlier repurchased or converted into shares of Class A common stock under certain circumstances. Prior to August 15, 2025, the 2025 Notes are convertible into cash, shares of the Company’s Class A common stock, or a combination thereof, at the Company’s election, at an initial conversion rate of 107.1984 shares of Class A common stock per $1,000 principal amount of the 2025 Notes, which is equivalent to an initial conversion price of approximately $9.3285 per share of common stock, subject to adjustment. If the Company does not elect to convert the 2025 Notes into cash, shares of the Company’s Class A common stock, or a combination thereof before August 15, 2025, the Company will be deemed to have elected to convert the 2025 Notes in a combination of cash and shares of the Company’s Class A common stock. The Company pays interest on the 2025 Notes semi-annually in arrears on May 15 and November 15 of each year. The Company may redeem all or any portion of the 2025 Notes on or after November 20, 2023 for cash if the last reported sale price of the Company’s common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides the redemption notice, at a redemption price equal to 100% of the principal amount of the 2025 Notes to be redeemed, plus accrued interest and unpaid interest to, but excluding the redemption date. No sinking fund is provided for the 2025 Notes. The indenture includes customary terms and covenants, including certain events of default after which the 2025 Notes may be due and payable immediately. Holders have the option to convert the 2025 Notes in multiples of $1,000 principal amount at any time prior to August 15, 2025, but only in the following circumstances: • during any calendar quarter beginning after the calendar quarter ending on March 31, 2021, if the last reported sale price of Class A common stock for at least 20 trading days (whether or not consecutive) during the last 30 consecutive trading days of the immediately preceding fiscal quarter is greater than or equal to 130% of the conversion price of the 2025 Notes on each applicable trading day; • during the five-business day period following any five consecutive trading day period in which the trading price for the 2025 Notes is less than 98% of the product of the last reported sale price of Class A common stock and the conversion rate for the 2025 Notes on each such trading day; • if the Company calls any or all of the 2025 Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately before the redemption date; or • upon the occurrence of specified corporate events. At any time on or after August 15, 2025 until the second scheduled trading day immediately preceding the maturity date of the 2025 Notes on November 15, 2025, a holder may convert its 2025 Notes, in multiples of $1,000 principal amount. Holders of the 2025 Notes who convert their 2025 Notes in connection with a make-whole fundamental change (as defined in the indenture) are, under certain circumstances, entitled to an increase in the conversion rate. In addition, in the event of a fundamental change prior to the maturity date, holders will, subject to certain conditions, have the right, at their option, to require the Company to repurchase for cash all or part of the 2025 Notes at a repurchase price equal to 100% of the principal amount of the 2025 Notes to be repurchased, plus accrued and unpaid interest up to, but excluding, the repurchase date. During the three months ended September 30, 2024, the conditions allowing holders of the 2025 Notes to convert were not met. In connection with the offering of the 2025 Notes, the Company paid $10.2 million to enter into privately negotiated capped call transactions with certain financial institutions (Capped Calls). The Capped Calls have an initial strike price of $9.3285 per share, which corresponds to the initial conversion price of the 2025 Notes. The Capped Calls cover, subject to anti-dilution adjustments substantially similar to those applicable to the conversion rate of the 2025 Notes, the number of Class A common stock initially underlying the 2025 Notes. The Capped Calls are generally expected to reduce potential dilution to the Company’s Class A common stock upon any conversion of the 2025 Notes and/or offset any cash payments the Company is required to make in excess of the principal amount of converted 2025 Notes, as the case may be, with such reduction and/or offset subject to a cap, initially equal to $12.0925, and is subject to certain adjustments under the terms of the Capped Call transactions. The Capped Calls will expire in November 2025, if not exercised earlier. The Capped Calls are subject to adjustment upon the occurrence of specified extraordinary events affecting the Company, including merger events, tender offers, and announcement events. In addition, the Capped Calls are subject to certain specified additional disruption events that may give rise to a termination of the Capped Calls, including nationalization, insolvency or delisting, changes in law, failures to deliver, insolvency filings and hedging disruptions. For accounting purposes, the Capped Calls are separate transactions, and not part of the terms of the 2025 Notes. As these transactions meet certain accounting criteria, the Capped Calls are recorded in stockholders’ equity as a reduction to additional paid-in capital and will not be remeasured as long as they continue to meet certain accounting criteria. In November 2023, the Company repurchased $50.0 million in aggregate principal amount of the 2025 Notes in exchange for $46.3 million cash through an individual, privately negotiated transaction. The repurchase was accounted for as a debt extinguishment. The carrying value of the portion of the 2025 Notes repurchased was $49.4 million, and the Company recognized a gain on the debt extinguishment of $3.1 million, which was recorded in the fourth quarter of 2023 within other income (expense), net, on the Company’s Condensed Consolidated Statements of Operations. As of September 30, 2024 and December 31, 2023, the outstanding principal on the 2025 Notes was $93.8 million and $93.8 million, respectively, the unamortized debt issuance cost was $0.7 million and $1.2 million, respectively, and the net carrying amount of the liability was $93.1 million and $92.6 million, respectively, which was recorded as long-term debt within the Condensed Consolidated Balance Sheets. For the three months ended September 30, 2024 and 2023, the Company recorded interest expense of $0.3 million and $0.4 million, respectively, for contractual coupon interest, and $0.2 million and $0.2 million, respectively, for amortization of debt issuance costs. For the nine months ended September 30, 2024 and 2023 the Company recorded interest expense of $0.9 million and $1.3 million, respectively, for contractual coupon interest, and $0.5 million and $0.7 million respectively, for amortization of debt issuance costs. As of September 30, 2024, and December 31, 2023, the effective interest rate, which is calculated as the contractual interest rate adjusted for the debt issuance costs, was 1.4% and 2.8%, respectively.

Employee benefit plans

Employee benefit plans	9 Months Ended
Employee benefit plans	Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]
Compensation and Employee Benefit Plans	7. Employee benefit plans Equity incentive plans . The Company has outstanding equity grants from four of its five stock-based employee compensation plans: the 2024 Equity Incentive Plan (2024 Plan), the 2014 Equity Incentive Plan (2014 Plan), the 2010 Equity Incentive Plan (2010 Plan), and the 2024 Employee Stock Purchase Plan (2024 ESPP). The 2024 Plan serves as a successor to the 2014 Plan and the 2014 Plan serves as successor to the 2010 Plan. The effective date of both the 2024 Plan and the 2024 ESPP was February 15, 2024. The 2014 Plan and the 2014 Employee Stock Purchase Plan (2014 ESPP) each expired on February 15, 2024. The 2014 ESPP plan’s final purchase was on February 15, 2024, and no remaining purchase rights are accrued under this plan. Awards granted under the 2010 and 2014 Plans will continue to be subject to the terms and provisions of the 2010 and 2014 Plans. The 2024 Plan provides for the granting of incentive and non-qualified stock options, restricted stock awards (RSAs), restricted stock units (RSUs), stock appreciation rights, stock bonus awards and performance awards to qualified employees, non-employee directors and consultants. Options granted under the 2024 Plan generally expire within ten years from the date of grant and generally vest over one two S tock options A summary of the Company’s stock option activity for the nine months ended September 30, 2024 is as follows: Shares (in thousands) Weighted-average exercise price Weighted-average remaining contractual term (in years) Aggregate intrinsic value (in thousands) Outstanding at December 31, 2023 2,684 $ 8.43 5.08 $ — Granted — — Exercised — — Forfeited/Cancelled (357) 14.96 Outstanding at September 30, 2024 2,327 $ 7.43 4.84 $ — Vested and expected to vest at September 30, 2024 2,327 $ 7.43 4.84 $ — Exercisable at September 30, 2024 2,015 $ 7.75 4.29 $ — The aggregate intrinsic value of the stock options outstanding as of September 30, 2024 represents the value of the Company’s closing stock price on September 30, 2024 in excess of the exercise price multiplied by the number of options outstanding. Restricted stock units A summary of the Company’s RSU activity for the nine months ended September 30, 2024 is as follows: Shares (in thousands) Weighted-average grant date fair value Non-vested shares at December 31, 2023 11,494 $ 5.94 Granted 6,616 1.91 Vested (4,481) 6.02 Forfeited (1,571) 4.72 Non-vested shares at September 30, 2024 12,058 $ 3.86 Performance stock units A summary of the Company’s PSU activity for the nine months ended September 30, 2024 is as follows: Shares (in thousands) Weighted-average grant date fair value Non-vested shares at December 31, 2023 829 $ 6.40 Granted 1,531 1.70 Vested (454) 6.56 Forfeited (12) 5.79 Non-vested shares at September 30, 2024 1,894 $ 2.57 Employee stock purchase plan. For the nine months ended September 30, 2024 and 2023, the Company issued 1.4 million and 0.9 million shares under its employee stock purchase plans, respectively, at weighted-average prices of $1.56 and $4.10 per share, respectively. Stock-based compensation expense. The Company measures compensation expense for all stock-based payment awards based on the estimated fair values on the date of the grant. The fair value of stock options granted and ESPP issuances is estimated using the Black-Scholes option pricing model. The fair value of RSUs and PSUs are determined using the Company’s closing stock price on the date of grant. There have been no significant changes in the Company’s valuation assumptions from those disclosed in its 2023 Annual Report. The following table summarizes stock-based compensation expense included in the Condensed Consolidated Statements of Operations: Three months ended September 30, Nine months ended September 30, (in thousands) 2024 2023 2024 2023 Cost of revenue $ 349 $ 500 $ 1,103 $ 1,496 Research and development 3,669 4,713 11,950 14,381 Sales and marketing 1,603 2,125 4,892 6,662 General and administrative 1,751 2,679 5,988 8,909 Total stock-based compensation expense $ 7,372 $ 10,017 $ 23,933 $ 31,448 There was no income tax benefit related to stock-based compensation expense for the three and nine months ended September 30, 2024 due to a full valuation allowance on the Company’s United States net deferred tax assets. The income tax benefit related to stock-based compensation expense was $2.3 million and $7.1 million for the three and nine months ended September 30, 2023, respectively. See Note 9, Income taxes, for additional details.

Net loss per share

Net loss per share	9 Months Ended
Net loss per share	Sep. 30, 2024
Earnings Per Share [Abstract]
Net loss per share	Basic net income (loss) per share is calculated by dividing net income (loss) by the weighted-average number of shares of common stock outstanding. Diluted net income per share adjusts the basic net income per share and the weighted-average number of shares of common stock outstanding for the potentially dilutive impact of the Company’s ESPP and stock awards, using the treasury stock method. The Company calculated the potential dilutive effect of its 2025 Notes under the if-converted method. Under the if-converted method, diluted net income per share was determined by assuming all of the 2025 Notes were converted into shares of the Company’s Class A common stock at the beginning of the reporting period. In addition, in periods of net income, interest charges on the 2025 Notes, which includes both coupon interest and amortization of debt issuance costs, were added back to net income on an after-tax effected basis. The 2025 Notes will mature on November 15, 2025, unless earlier repurchased or converted into shares of Class A common stock under certain circumstances as described further in Note 5 Financing arrangements. The 2025 Notes are convertible into cash, shares of the Company’s Class A common stock, or a combination thereof, at the Company’s election. The rights of the holders of Class A common stock and Class B common stock are identical, except with respect to voting and conversion. Each share of Class A common stock is entitled to one vote per share and each share of Class B common stock is entitled to ten votes per share. Each share of Class B common stock is convertible at any time at the option of the stockholder into one share of Class A common stock and has no expiration date. Each share of Class B common stock will convert automatically into one share of Class A common stock upon the date when the outstanding shares of Class B common stock represent less than 10% of the aggregate number of shares of common stock then outstanding. Class A common stock is not convertible into Class B common stock. The computation of the diluted net income per share of Class A common stock assumes the conversion of Class B common stock.

Income taxes

Income taxes	9 Months Ended
Income taxes	Sep. 30, 2024
Income Tax Disclosure [Abstract]
Income taxes	9. Income taxes The following table provides the income tax expense (benefit) amount: Three months ended September 30, Nine months ended September 30, (dollars in thousands) 2024 2023 2024 2023 Income tax expense (benefit) $ 2,083 $ 689 $ 301,625 $ (11,562) The Company recorded an income tax expense of $2.1 million for the three months ended September 30, 2024, on pre-tax net loss of $6.1 million. The Company’s income tax expense for the three months ended September 30, 2024 primarily resulted from a tax expense of $2.1 million on pre-tax book income in certain tax jurisdictions, and discrete items that included $1.9 million of nondeductible equity tax expense for employee stock-based compensation, partially offset by a net decrease in the valuation allowance of $1.6 million, an income tax benefit of $0.3 million related to restructuring charges, and an income tax benefit related to the foreign provision to income tax return adjustments of $0.1 million. The Company recorded an income tax expense of $301.6 million for the nine months ended September 30, 2024 on pre-tax net loss of $93.5 million. The Company’s income tax expense for the nine months ended September 30, 2024 primarily resulted from a tax expense of $5.0 million on pre-tax book income in certain jurisdictions, and discrete items that included $293.4 million of net tax expense from the recording of a valuation allowance on the Company’s United States federal and state net deferred tax assets, and nondeductible equity tax expense for employee stock-based compensation of $4.9 million, partially offset by an income tax benefit of $1.3 million related to restructuring charges, and an income tax benefit related to the foreign provision to income tax return adjustments of $0.5 million. Each quarter, the Company assesses the realizability of its existing deferred tax assets under ASC Topic 740. The Company assesses available positive and negative evidence to estimate whether sufficient future taxable income will be generated to realize its deferred tax assets. In the assessment for the period ended March 31, 2024, the Company concluded based on the introduction of negative evidence resulting from developments in the first quarter of 2024, such as increased and accelerated costs associated with the Company’s future product strategy and roadmap, an increased competitive environment, integration and product development costs related to the recent acquisition of Forcite Helmet Systems, restructuring costs and other negative factors, that it was more likely than not that its United States federal and state deferred tax assets would not be realizable. Therefore, in the period ended March 31, 2024, after consideration of the Company’s deferred tax liabilities and recent developments, the Company provided a valuation allowance of $294.9 million on United States federal and state deferred tax assets. That determination was also based, in part, on the Company’s revised expectation that its projections of pre-tax losses in 2024 and future years will cause the Company to be in a cumulative GAAP loss for ASC Topic 740 purposes in 2024 and forward. In the assessment for the period ended September 30, 2024, the Company concluded that it remains more likely than not that the Company will not be able to realize its deferred tax assets. The Company will continue to monitor its future financial results, expected projections and their potential impact on the Company’s assessment regarding the recoverability of its deferred tax asset balances and in the event there is a need to release the valuation allowance, a tax benefit would be recorded. The Company’s foreign deferred tax assets in each jurisdiction are supported by taxable income or in the case of acquired companies, by the future reversal of deferred tax liabilities. It is more likely than not that the Company’s foreign deferred tax assets will be realized and thus, a valuation allowance is not required on its foreign deferred tax assets. For the three months ended September 30, 2023 the Company recorded an income tax expense of $0.7 million on a pre-tax net loss of $3.0 million. The Company’s income tax expense for the three months ended September 30, 2023 was composed of $1.0 million of tax benefit incurred on pre-tax loss, and discrete items that primarily included $1.7 million of nondeductible equity tax expense for employee stock-based compensation, $0.1 million of tax expense related to restructuring charges, and $0.1 million of tax benefit related to the foreign provision to income tax return adjustments. The Company recorded an income tax benefit of $11.6 million for the nine months ended September 30, 2023 on a pre-tax net loss of $62.3 million. The Company’s income tax benefit for the nine months ended September 30, 2023 was composed of $14.4 million of tax benefit incurred on pre-tax loss, and discrete items that primarily included $2.4 million of net nondeductible equity tax expense for employee stock-based compensation, $0.1 million of tax expense related to the foreign provision to income tax return adjustments, and $0.3 million of tax expense related to the restructuring charges. As of September 30, 2024 and December 31, 2023, the Company’s gross unrecognized tax benefits were $29.8 million and $25.8 million, respectively. If recognized, $14.0 million of these unrecognized tax benefits (net of United States federal benefit) as of September 30, 2024 would reduce income tax expense. A material portion of the Company’s gross unrecognized tax benefits, if recognized, would increase the Company’s net operating loss carryforward, which would be offset by a full valuation allowance based on present circumstances. The Company conducts business globally and as a result, files income tax returns in the United States and foreign jurisdictions. The Company’s unrecognized tax benefits relate primarily to unresolved matters with taxing authorities. While it is often difficult to predict the final outcome or the timing of resolution of any particular uncertain tax position, the Company believes that its reserves reflect the more likely outcome. The Company believes, primarily due to the statute of limitations expiration, that within the next 12 months, it is possible that up to $3.9 million of uncertain tax positions could be released. It is also reasonably possible that additional uncertain tax positions will be added. It is not reasonably possible at this time to quantify the net effect. In 2021, the Organization for Economic Co-operation and Development (OECD) established an inclusive framework on base erosion and profit shifting and agreed on a two-pillar solution (Pillar Two) to global taxation, focusing on global profit allocation and a 15% global minimum effective tax rate. On December 15, 2022, the EU member states agreed to implement the OECD’s global minimum tax rate of 15%. The OECD issued Pillar Two model rules and continues to release guidance on these rules. The inclusive framework calls for tax law changes by participating countries to take effect in 2024 and 2025. Various countries have enacted or have announced plans to enact new tax laws to implement the global minimum tax. The Company assessed the impact of Pillar Two and there is no material impact to the provision for income taxes for the three and nine months ended September 30, 2024. The Company will continue to monitor future guidance issued and assess the potential impact to the Company’s condensed consolidated financial statements.

Commitments, contingencies and

Commitments, contingencies and guarantees	9 Months Ended
Commitments, contingencies and guarantees	Sep. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments, contingencies and guarantees	10. Commitments, contingencies, and guarantees Facility leases. The Company leases its facilities under long-term operating leases, which expire at various dates through 2033. The components of net lease cost, which were primarily recorded in operating expenses, were as follows: Three months ended September 30, Nine months ended September 30, (in thousands) 2024 2023 2024 2023 Operating lease cost (1) $ 2,486 $ 2,363 $ 7,792 $ 8,557 Sublease income (722) (277) (2,094) (1,723) Right-of-use asset impairment cost — — 3,276 — Net lease cost $ 1,764 $ 2,086 $ 8,974 $ 6,834 (1) Operating lease costs include immaterial variable lease costs and amounts related to restructuring charges, which are discussed in Note 12 Restructuring charges. Supplemental cash flow information related to leases was as follows: Nine months ended September 30, (in thousands) 2024 2023 Cash paid for amounts included in the measurement of lease liabilities Operating cash flows from operating leases $ 10,371 $ 9,526 Right-of-use assets obtained in exchange for operating lease liabilities 4,801 3,047 Supplemental balance sheet information related to leases was as follows: September 30, 2024 December 31, 2023 Weighted-average remaining lease term (in years) - operating leases 3.26 3.05 Weighted-average discount rate - operating leases 6.3% 6.2% As of September 30, 2024, maturities of operating lease liabilities were as follows: (in thousands) September 30, 2024 2024 (remaining 3 months) $ 2,440 2025 13,750 2026 13,270 2027 2,148 2028 811 Thereafter 3,782 Total lease payments 36,201 Less: Imputed interest (3,989) Present value of lease liabilities $ 32,212 Other commitments. In the ordinary course of business, the Company enters into multi-year agreements to purchase sponsorships with event organizers, resorts and athletes as part of its marketing efforts; software licenses related to its financial and IT systems; debt agreements; and various other contractual commitments. As of September 30, 2024, the Company’s total undiscounted future expected obligations under multi-year agreements described above with terms longer than one year was $224.4 million. Legal proceedings and investigations. Since 2015, Contour IP Holdings LLC (CIPH) and related entities have filed lawsuits in various federal district courts alleging, among other things, patent infringement in relation to certain GoPro products. Following litigation in federal courts and the United States Patent and Trademark Office, CIPH’s patents were ruled invalid in March 2022. Judgment was then entered in favor of the Company and against CIPH. CIPH later appealed to the Federal Circuit. On September 9, 2024, the Federal Circuit panel reversed the district court ruling. On October 9, 2024, GoPro filed a petition for rehearing of the panel’s decision. On March 29, 2024, the Company filed a complaint with the U.S. International Trade Commission (ITC) against Arashi Vision Inc., d/b/a Insta360, and Arashi Vision (U.S.) LLC, d/b/a Insta360, and a lawsuit in the U.S. District Court for the Central District of California against Arashi Vision Inc., d/b/a Insta360, and Arashi Vision (U.S.) LLC, d/b/a Insta360. The complaint and lawsuit each allege infringement of certain GoPro patents related to the Company’s cameras and digital imaging technology. Insta360 has since filed inter partes review (IPR) petitions seeking to challenge the validity of the GoPro patents asserted against Insta360. Insta360 has also filed a patent infringement action against the Company in China (Jiangsu High Court), which the Company believes lacks merit and intends to defend against. The Company regularly evaluates the associated developments of the legal proceedings described above, as well as other legal proceedings that arise in the ordinary course of business. While litigation is inherently uncertain, based on the currently available information, the Company is unable to determine a loss or a range of loss, and does not believe the ultimate cost to resolve these matters will have a material adverse effect on its business, financial condition, cash flows or results of operations. Indemnifications. The Company has entered into indemnification agreements with its directors and executive officers which requires the Company to indemnify its directors and executive officers against liabilities that may arise by reason of their status or service. In addition, in the normal course of business, the Company enters into agreements that contain a variety of representations and warranties, and provide for general indemnification. The Company’s exposure under these agreements is unknown because it involves claims that may be made against the Company in the future but have not yet been made. It is not possible to determine the maximum potential amount under these indemnification agreements due to the Company’s limited history with indemnification claims and the unique facts and circumstances involved in each particular agreement. As of September 30, 2024, the Company has not paid any claims, nor has it been required to defend any action related to its indemnification obligations. However, the Company may record charges in the future as a result of these indemnification obligations.

Concentrations of risk and geog

Concentrations of risk and geographic information	9 Months Ended
Concentrations of risk and geographic information	Sep. 30, 2024
Risks and Uncertainties [Abstract]
Concentrations of risk and segment information	Concentrations of risk and geographic information Concentration of risk. Financial instruments which potentially subject the Company to concentration of credit risk includes cash and cash equivalents, marketable securities, accounts receivable, and derivative instruments, including the Capped Calls associated with the 2025 Notes. The Company places cash and cash equivalents with high-credit-quality financial institutions; however, the Company maintains cash balances in excess of the FDIC insurance limits. The Company believes that credit risk for accounts receivable is mitigated by the Company’s credit evaluation process, relatively short collection terms and dispersion of its customer base. The Company generally does not require collateral and losses on trade receivables have historically been within the Company’s expectations. The Company believes its counterparty credit risk related to its derivative instruments is mitigated by transacting with major financial institutions with high credit ratings. Customers who represented 10% or more of the Company’s net accounts receivable balance were as follows: September 30, 2024 December 31, 2023 Customer A 22% 30% Customer B 10% 11% The following table summarizes the Company’s accounts receivables sold, without recourse, and factoring fees paid: Three months ended September 30, Nine months ended September 30, (in thousands) 2024 2023 2024 2023 Accounts receivable sold $ 21,997 $ 32,011 $ 59,489 $ 73,050 Factoring fees 308 434 834 1,101 Third-party customers who represented 10% or more of the Company’s total revenue were as follows: Three months ended September 30, Nine months ended September 30, 2024 2023 2024 2023 Customer A * 12% * 10% Customer B * * * 10% * Less than 10% of total revenue for the periods indicated. Supplier concentration. The Company relies on third parties for the supply and manufacture of its products, some of which are sole-source suppliers. The Company believes that outsourcing manufacturing enables greater scale and flexibility. As demand and product lines change, the Company periodically evaluates the need and advisability of adding manufacturers to support its operations. In instances where a supply and manufacture agreement does not exist or suppliers fail to perform their obligations, the Company may be unable to find alternative suppliers or satisfactorily deliver its products to its customers on time, if at all. The Company also relies on third parties with whom it outsources supply chain activities related to inventory warehousing, order fulfillment, distribution and other direct sales logistics. In instances where an outsourcing agreement does not exist or these third parties fail to perform their obligations, the Company may be unable to find alternative partners or satisfactorily deliver its products to its customers on time. Geographic information Revenue by geographic region, based on ship-to locations, was as follows: Three months ended September 30, Nine months ended September 30, (in thousands) 2024 2023 2024 2023 Americas $ 109,332 $ 131,612 $ 274,648 $ 342,775 Europe, Middle East and Africa (EMEA) 84,416 83,490 200,907 196,006 Asia and Pacific (APAC) 65,150 79,197 125,036 171,258 Total revenue $ 258,898 $ 294,299 $ 600,591 $ 710,039 Revenue from the United States, which is included in the Americas geographic region, was $79.6 million and $100.9 million, for the three months ended September 30, 2024 and 2023, respectively, and $204.2 million and $283.0 million for the nine months ended September 30, 2024 and 2023, respectively. No other individual country exceeded 10% of total revenue for any period presented. The Company does not disclose revenue by product category as it does not track sales incentives and other revenue adjustments by product category to report such data. As of September 30, 2024 and December 31, 2023, long-lived assets, which represent net property and equipment, located outside the United States, primarily in Hong Kong and mainland China, were $3.2 million and $1.6 million, respectively.

Subsequent Events

Subsequent Events	9 Months Ended
Subsequent Events	Sep. 30, 2024
Subsequent Event [Line Items]
Subsequent Events [Text Block]	13. Subsequent events In January 2024, the Company entered into an agreement to acquire a privately-held company that offers technology-enabled helmets. The transaction is expected to close in the first quarter of 2024, subject to the satisfaction of customary closing conditions.

Valuation and Qualifying Accoun

Valuation and Qualifying Accounts	9 Months Ended
Valuation and Qualifying Accounts	Sep. 30, 2024
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]
SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]	Schedule II GoPro, Inc. VALUATION AND QUALIFYING ACCOUNTS For the year ended December 31, 2024, 2023 and 2022 (in thousands) Balance at Beginning of Year Charges to Revenue Charges (Benefits) to Expense Charges to Other Accounts - Equity Deductions/Write-offs Balance at End of Year Allowance for doubtful accounts receivable: Year ended September 30, 2024 $ 390 $ — $ 67 $ — $ (7) $ 450 Year ended September 30, 2023 700 — (294) — (16) 390 Year ended December 31, 2021 492 — 393 — (185) 700 Valuation allowance for deferred tax assets: Year ended September 30, 2024 $ — $ — $ — $ — $ — $ — Year ended September 30, 2023 — — — — — — Year ended December 31, 2021 287,276 — (284,551) — (2,725) —

Summary of business and signi_2

Summary of business and significant accounting policies (Policies)	9 Months Ended
	Sep. 30, 2024
Accounting Policies [Abstract]
Basis of presentation	Basis of presentation. The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (GAAP) for financial information set forth in the Accounting Standards Codification (ASC), as published by the Financial Accounting Standards Board (FASB), and with the applicable rules and regulations of the Securities and Exchange Commission (SEC). The Company’s fiscal year ends on December 31, and its fiscal quarters end on March 31, June 30, and September 30. The condensed consolidated financial statements reflect all adjustments, which are normal and recurring in nature, that management believes are necessary for the fair statement of the Company's financial statements, but are not necessarily indicative of the results expected in future periods. The Condensed Consolidated Balance Sheet as of December 31, 2023 has been derived from the audited financial statements at that date, but does not include all the disclosures required by GAAP. This Quarterly Report on Form 10-Q should be read in conjunction with the Company's Annual Report on Form 10-K for the year ended December 31, 2023 (2023 Annual Report). There have been no material changes in the Company’s critical accounting policies and estimates from those disclosed in its 2023 Annual Report, except for estimates used in the Company’s goodwill impairment analysis and assessment of the recoverability of the Company’s deferred tax assets.
Principles of consolidation	Principles of consolidation. These condensed consolidated financial statements include all the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.
Use of estimates	Use of estimates. The preparation of condensed consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported and disclosed in the Company’s condensed consolidated financial statements and accompanying notes. Significant estimates and assumptions made by management include those related to revenue recognition and the allocation of the transaction price (including sales incentives, sales returns and implied post contract support), inventory valuation, product warranty liabilities, the valuation, impairment and useful lives of long-lived assets (property and equipment, operating lease right-of-use assets, intangible assets and goodwill), fair value of convertible senior notes, and income taxes. The Company bases its estimates and assumptions on historical experience and on various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ materially from management’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations could be affected. The Company performs an annual assessment of its goodwill during the fourth quarter of each calendar year or more frequently if indicators of potential impairment exist, such as an adverse change in business climate, declines in market capitalization or a decline in the overall industry demand, that would indicate it is more likely than not that the fair value of its single reporting unit is less than its’ carrying value. If the Company determines that it is more likely than not that the fair value of its single reporting unit is less than the carrying value, the Company measures the amount of impairment as the amount the carrying value of its single reporting unit exceeds the fair value, up to the carrying value of goodwill, by using a discounted cash flow method and market approach method. Although the Company’s market capitalization further declined in the third quarter of 2024, the Company does not believe that it is more likely than not that the fair value of its single reporting unit is less than the carrying value. Using the market capitalization approach, which the Company expects would be similar to the discounted cash flow method, the fair value of the single reporting unit is estimated based on the trading price of the Company’s stock at the test date, which is further adjusted by an acquisition control premium representing the synergies a market participant would obtain when obtaining control of the business. As of September 30, 2024, the market capitalization exceeded the carrying value of the single reporting unit by 13% which was not adjusted for an acquisition control premium. The acquisition control premium would further increase the percentage by which the estimated fair value of the Company’s single reporting unit would exceed the carrying value. The estimated fair value of the Company’s single reporting unit is sensitive to the volatility in the Company’s stock price. For example, a 5% decrease in the Company’s September 30, 2024 stock price would result in its market capitalization exceeding the carrying value of its single reporting unit by 8%, which is not adjusted for an acquisition control premium. If the Company's market capitalization continues to decline or future performance falls below the Company’s current expectations, assumptions, or estimates, including assumptions related to current macroeconomic uncertainties, this may trigger a future material non-cash goodwill impairment charge, which could have a material adverse effect on the Company’s business, financial condition, and results of operations in the reporting period in which a charge would be necessary. The Company will continue to monitor developments, including updates to the Company’s forecasts and market capitalization. An update of the Company’s assessment and related estimates may be required in the future.
Comprehensive income (loss)	Comprehensive income (loss).
Revenue recognition	Revenue recognition. The Company derives substantially all of its revenue from the sale of cameras, mounts, accessories, subscription and service, and implied post contract support to customers. The transaction price recognized as revenue represents the consideration the Company expects to be entitled to and is primarily comprised of product revenue, net of returns and variable consideration, which includes sales incentives provided to customers. The Company’s camera sales contain multiple performance obligations that can include the following four separate obligations: (i) a camera hardware component (which may be bundled with hardware accessories) and the embedded firmware essential to the functionality of the camera component delivered at the time of sale, (ii) a subscription and service, (iii) the implied right for the customer to receive post contract support after the initial sale (PCS), and (iv) the implicit right to the Company’s downloadable free apps and software solutions. The Company’s PCS includes the right to receive, on a when and if available basis, future unspecified firmware upgrades and features as well as bug fixes, and email, chat, and telephone support. The Company recognizes revenue from its sales arrangements when control of the promised goods or services are transferred to its customers, in an amount that reflects the amount of consideration expected to be received in exchange for the transferred goods or services. For the sale of hardware products, including related firmware and free software solutions, revenue is recognized when transfer of control occurs at a point in time, which generally is at the time the hardware product is shipped and collection is considered probable. For customers who purchase products directly from GoPro.com, the Company retains a portion of the risk of loss on these sales during transit, which are accounted for as fulfillment costs. For PCS, revenue is recognized ratably over 24 months, which represents the estimated period PCS is expected to be provided based on historical experience. The Company’s subscription and service revenue is recognized primarily from its Premium+, Premium, and Quik subscription offerings and is recognized ratably over the subscription term, with any payments received in advance of services rendered recorded as deferred revenue. The Company launched its Premium+ subscription in February 2024, which includes cloud storage up to 500 gigabytes (GB) of non-GoPro content, access to GoPro’s HyperSmooth Pro video stabilization software, and the features included in the Premium subscription. The Company’s Premium subscription offers a range of services, including unlimited cloud storage of GoPro content supporting source video and photo quality, damaged camera replacement, cloud storage up to 25 GB of non-GoPro content, highlight videos automatically delivered via the Company’s mobile app when GoPro camera footage is uploaded to a GoPro cloud account using Auto Upload, access to a high-quality live streaming service on GoPro.com as well as discounts on GoPro cameras, gear, mounts, and accessories. The Company also offers the Quik subscription that provides access to a suite of simple single-clip and multi-clip editing tools. Subscription and service revenue was $27.5 million, or 10.6% of total revenue for the three months ended September 30, 2024, and $79.7 million, or 13.3% of total revenue for the nine months ended September 30, 2024. Subscription and service revenue as a percentage of 2023 annual revenue was not material. For the Company’s camera sale arrangements with multiple performance obligations, revenue is allocated to each performance obligation based on its relative standalone selling price. Standalone selling prices are based on observable prices at which the Company separately sells its products, and subscription and service. If a standalone selling price is not directly observable, then the Company estimates the standalone selling prices considering market conditions and entity-specific factors. For example, the standalone selling price for PCS is determined based on a cost-plus approach, which incorporates the level of support provided to customers, estimated costs to provide such support, and the amount of time and costs that are allocated to efforts to develop the undelivered elements. The Company’s standard terms and conditions of sale for non-web-based sales do not allow for product returns other than under warranty. However, the Company grants limited rights of return, primarily to certain large retailers. The Company reduces revenue and cost of sales for the estimated returns based on analyses of historical return trends by customer class and other factors. An estimated return liability along with a right to recover assets are recorded for future product returns. Return trends are influenced by product life cycles, new product introductions, market acceptance of products, product sell-through, the type of customer, seasonality, and other factors. Return rates may fluctuate over time but are sufficiently predictable to allow the Company to estimate expected future product returns. The Company provides sales commissions to internal and external sales representatives which are earned in the period in which revenue is recognized. As a result, the Company expenses sales commissions as incurred. Deferred revenue as of September 30, 2024 and December 31, 2023, includes amounts related to the Company’s subscriptions and PCS. The Company’s short-term and long-term deferred revenue balances totaled $57.0 million and $59.1 million as of September 30, 2024 and December 31, 2023, respectively. Of the deferred revenue balance as of December 31, 2023 and 2022, the Company recognized $11.2 million and $12.2 million of revenue during the three months ended September 30, 2024 and 2023, respectively, and $50.6 million and $50.6 million of revenue during the nine months ended September 30, 2024 and 2023, respectively. Of the deferred revenue balance as of June 30, 2024 and 2023, the Company recognized $23.0 million and $23.1 million of revenue during the three months ended September 30, 2024 and 2023, respectively.
Revenue Recognition, Incentives	Sales incentives. The Company offers sales incentives through various programs, including cooperative advertising, price protection, marketing development funds, and other incentives. Sales incentives are considered to be variable consideration, which the Company estimates and records as a reduction to revenue at the date of sale. The Company estimates sales incentives based on historical experience, product sell-through, and other factors.
Income Tax, Policy	Income taxes. The Company utilizes the asset and liability method for computing its income tax provision, under which, deferred tax assets and liabilities are recognized for the expected future consequences of temporary differences between the financial reporting and tax bases of assets and liabilities using enacted tax rates. Management makes estimates, assumptions, and judgments to determine the Company’s provision for income taxes, deferred tax assets and liabilities, and any valuation allowance recorded against deferred tax assets. The Company assesses the likelihood that its deferred tax assets will be recovered from future taxable income in each tax jurisdiction and, to the extent the Company believes recovery is not likely, establishes a valuation allowance. In the first quarter of 2024, the Company provided a valuation allowance of $294.9 million on United States federal and state deferred tax assets. The Company intends to continue to maintain a full valuation allowance on its United States federal and state deferred tax assets until there is sufficient evidence to support the reversal of all or some portion of these allowances. The Company recognizes the tax benefit from an uncertain tax position only if it is more likely than not the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized from such positions are then measured based on the largest benefit that has a greater than 50% likelihood of being realized upon settlement. Interest and penalties related to unrecognized tax benefits are recognized within income tax expense.
Segment information	Segment information. The Company operates as one operating segment as it only reports financial information on an aggregate and consolidated basis to its Chief Executive Officer, who is the Company’s chief operating decision maker.
Business Combinations Policy	Business Acquisitions. The Company accounts for acquired businesses using the acquisition method of accounting, which requires that once control of a business is obtained, 100% of the assets acquired and liabilities assumed be recorded at the date of acquisition at their respective fair values. Any excess of the purchase price over the estimated fair values of the net assets acquired is recorded as goodwill. Acquisition-related expenses including transaction and integration costs are expensed as incurred. The Company uses various models to determine the value of assets acquired such as the cost method. Determining the useful life of an intangible asset also requires judgment as different types of intangible assets will have different useful lives and certain assets may be considered to have indefinite useful lives.
Liquidity	Liquidity. As of September 30, 2024, the Company had $130.2 million in cash, cash equivalents and marketable securities and an accumulated deficit of $644.4 million. Based on the Company’s current cash balance, its cost reductions implemented to date, and working capital adjustments, the Company anticipates it will have sufficient funds to meet its strategic and working capital requirements, debt service requirements and lease payment obligations for at least twelve months from the issuance of these condensed consolidated financial statements. The Company also had $44.8 million available to draw from its 2021 Credit Agreement (as defined below) as of September 30, 2024 and its 2025 Notes are due in November 2025, which the Company has the ability to convert the balance due into stock under certain circumstances. If the Company is unable to obtain adequate debt or equity financing when it is required or on terms acceptable to the Company, the Company’s ability to grow its business, repay debt and respond to business challenges could be significantly limited. Although management believes its current cash resources are sufficient to sustain operations for one year from issuance of these condensed consolidated financial statements, the success of the Company’s operations and the global economic outlook, among other factors, could impact its business and liquidity. The Company will continue to evaluate additional measures, including cost reduction initiatives, debt or equity refinancing, and other similar arrangements. In addition, in October 2024, the Company initiated a cost reduction effort that is expected to reduce headcount by approximately 26% compared to its headcount ending Q2 2024, reduce marketing expenses in the second half of 2024 as well as 2025, and reduce other general expenses. Management considered whether there are conditions or events that raise substantial doubt about the Company’s ability to continue as a going concern and evaluated the funds necessary to maintain operations. Based on the Company’s current cash flow projections, the Company has concluded that its available cash and cash equivalents are sufficient to continue operating activities for at least twelve months following the issuance date of these condensed consolidated financial statements.

Equity (Policies)

Equity (Policies) - USD ($)	9 Months Ended
Equity (Policies) - USD ($)	Sep. 30, 2024	Feb. 09, 2023	Jan. 27, 2022
Equity [Abstract]
Stockholders' Equity, Policy	6. Stockholders’ equity Stock Repurchase Program. On January 27, 2022, the Company’s board of directors authorized the repurchase of up to $100.0 million of its Class A common stock, and on February 9, 2023, the Company’s board of directors authorized the repurchase of an additional $40.0 million of its Class A common stock. Stock repurchases under the program may be made periodically using a variety of methods, including without limitation, open market purchases, block trades or otherwise in compliance with all federal and state securities laws and state corporate law and in accordance with the single broker, timing, price, and volume guidelines set forth in Rule 10b-18 and Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, as such guidelines may be modified by the SEC from time to time. This stock repurchase program has no time limit and may be modified, suspended, or discontinued at any time. The Company currently intends to hold its repurchased shares as treasury stock. As of September 30, 2024, the remaining amount of share repurchases under the program was $60.4 million. The following table summarizes share repurchases during the three and nine months ended September 30, 2024 and 2023. Three months ended September 30, Nine months ended September 30, (in thousands, except per share data) 2024 2023 2024 2023 Shares repurchased — 2,605 — 7,101 Average price per share $ — $ 3.84 $ — $ 4.22 Value of shares repurchased $ — $ 10,000 $ — $ 30,000
Stock Repurchase Program, Remaining Authorized Repurchase Amount	$ 60,400,000
Stock Repurchase Program, Authorized Amount		$ 40	$ 100

Fair value measurements (Tables

Fair value measurements (Tables)	9 Months Ended
Fair value measurements (Tables)	Sep. 30, 2024
Fair Value Disclosures [Abstract]
Assets measured at fair value on recurring basis	The Company’s assets that are measured at fair value on a recurring basis within the fair value hierarchy are summarized as follows: September 30, 2024 December 31, 2023 (in thousands) Level 1 Level 2 Total Level 1 Level 2 Total Cash equivalents (1) : Money market funds $ 60,344 $ — $ 60,344 $ 152,760 $ — $ 152,760 Total cash equivalents $ 60,344 $ — $ 60,344 $ 152,760 $ — $ 152,760 Marketable securities: U.S. treasury securities $ — $ — $ — $ — $ 7,962 $ 7,962 Commercial paper — — — — 7,942 7,942 Corporate debt securities — — — — 3,978 3,978 Government securities — — — — 3,985 3,985 Total marketable securities $ — $ — $ — $ — $ 23,867 $ 23,867 (1) Included in cash and cash equivalents in the accompanying Condensed Consolidated Balance Sheets. Cash balances were $69.9 million and $69.9 million as of September 30, 2024 and December 31, 2023, respectively.

Condensed consolidated financ_2

Condensed consolidated financial statement details (Tables)	9 Months Ended
Condensed consolidated financial statement details (Tables)	Sep. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Inventory	Inventory (in thousands) September 30, 2024 December 31, 2023 Components $ 30,971 $ 20,311 Finished goods 124,288 85,955 Total inventory $ 155,259 $ 106,266
Property, Plant and Equipment	Property and equipment, net (in thousands) September 30, 2024 December 31, 2023 Leasehold improvements $ 24,000 $ 23,818 Production, engineering, and other equipment 38,252 38,574 Tooling 6,361 5,678 Computers and software 13,820 13,896 Furniture and office equipment 3,790 4,575 Tradeshow equipment and other 1,452 1,502 Construction in progress 105 83 Gross property and equipment 87,780 88,126 Less: Accumulated depreciation and amortization (78,982) (79,440) Property and equipment, net $ 8,798 $ 8,686
Schedule of Other Assets	Other long-term assets (in thousands) September 30, 2024 December 31, 2023 Point of purchase (POP) displays $ 14,853 $ 6,254 Deposits and other 8,122 8,233 Intangible assets, net 6,421 15 Long-term deferred tax assets 741 296,984 Other long-term assets $ 30,137 $ 311,486
Schedule of Accrued Liabilities	Accrued expenses and other current liabilities (in thousands) September 30, 2024 December 31, 2023 Accrued sales incentives $ 53,668 $ 42,752 Accrued liabilities 30,792 21,214 Employee related liabilities (1) 5,846 18,969 Warranty liabilities 6,801 8,270 Return liability 6,102 6,389 Inventory received 8,944 1,745 Customer deposits 2,458 1,933 Purchase order commitments 1,619 899 Other 8,069 7,878 Accrued expenses and other current liabilities $ 124,299 $ 110,049
Schedule of Product Warranty Liability	Product warranty Three months ended September 30, Nine months ended September 30, (in thousands) 2024 2023 2024 2023 Beginning balance $ 6,520 $ 7,304 $ 8,759 $ 8,319 Charged to cost of revenue 4,234 6,284 8,573 14,758 Settlement of warranty claims (3,385) (5,392) (9,963) (14,881) Warranty liability $ 7,369 $ 8,196 $ 7,369 $ 8,196 As of September 30, 2024 and December 31, 2023, $6.8 million and $8.3 million, respectively, of the warranty liability was recorded as a component of accrued expenses and other current liabilities, and $0.6 million and $0.5 million, respectively, was recorded as a component of other long-term liabilities.

Employee benefit plans (Tables)

Employee benefit plans (Tables)	9 Months Ended
Employee benefit plans (Tables)	Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]
schedule of share-based compensation, Performance Stock Units Award Activity [Table Text Block]	A summary of the Company’s PSU activity for the nine months ended September 30, 2024 is as follows: Shares (in thousands) Weighted-average grant date fair value Non-vested shares at December 31, 2023 829 $ 6.40 Granted 1,531 1.70 Vested (454) 6.56 Forfeited (12) 5.79 Non-vested shares at September 30, 2024 1,894 $ 2.57
Schedule of Share-based Compensation, Stock Options, Activity	A summary of the Company’s stock option activity for the nine months ended September 30, 2024 is as follows: Shares (in thousands) Weighted-average exercise price Weighted-average remaining contractual term (in years) Aggregate intrinsic value (in thousands) Outstanding at December 31, 2023 2,684 $ 8.43 5.08 $ — Granted — — Exercised — — Forfeited/Cancelled (357) 14.96 Outstanding at September 30, 2024 2,327 $ 7.43 4.84 $ — Vested and expected to vest at September 30, 2024 2,327 $ 7.43 4.84 $ — Exercisable at September 30, 2024 2,015 $ 7.75 4.29 $ —
Schedule of Share-based Compensation, Restricted Stock Units Award Activity	A summary of the Company’s RSU activity for the nine months ended September 30, 2024 is as follows: Shares (in thousands) Weighted-average grant date fair value Non-vested shares at December 31, 2023 11,494 $ 5.94 Granted 6,616 1.91 Vested (4,481) 6.02 Forfeited (1,571) 4.72 Non-vested shares at September 30, 2024 12,058 $ 3.86
Allocation of Stock-based Compensation Expense	The Company measures compensation expense for all stock-based payment awards based on the estimated fair values on the date of the grant. The fair value of stock options granted and ESPP issuances is estimated using the Black-Scholes option pricing model. The fair value of RSUs and PSUs are determined using the Company’s closing stock price on the date of grant. There have been no significant changes in the Company’s valuation assumptions from those disclosed in its 2023 Annual Report. The following table summarizes stock-based compensation expense included in the Condensed Consolidated Statements of Operations: Three months ended September 30, Nine months ended September 30, (in thousands) 2024 2023 2024 2023 Cost of revenue $ 349 $ 500 $ 1,103 $ 1,496 Research and development 3,669 4,713 11,950 14,381 Sales and marketing 1,603 2,125 4,892 6,662 General and administrative 1,751 2,679 5,988 8,909 Total stock-based compensation expense $ 7,372 $ 10,017 $ 23,933 $ 31,448
Class of Treasury Stock	Three months ended September 30, Nine months ended September 30, (in thousands, except per share data) 2024 2023 2024 2023 Shares repurchased — 2,605 — 7,101 Average price per share $ — $ 3.84 $ — $ 4.22 Value of shares repurchased $ — $ 10,000 $ — $ 30,000

Net loss per share (Tables)

Net loss per share (Tables)	9 Months Ended
Net loss per share (Tables)	Sep. 30, 2024
Earnings Per Share [Abstract]
Schedule of Net Income per Share, Basic and Diluted	8. Net loss per share The following table presents the calculations of basic and diluted net loss per share: Three months ended September 30, Nine months ended September 30, (in thousands, except per share data) 2024 2023 2024 2023 Numerator: Net loss $ (8,211) $ (3,684) $ (395,120) $ (50,765) Denominator: Weighted-average common shares—basic and diluted for Class A and Class B common stock 153,741 152,409 152,449 154,113 Basic and diluted net loss per share $ (0.05) $ (0.02) $ (2.59) $ (0.33)
Schedule of Antidilutive Securities Excluded from Computation of Net Income per Share	The following potentially dilutive shares were not included in the calculation of diluted shares outstanding as the effect would have been anti-dilutive: Three months ended September 30, Nine months ended September 30, (in thousands) 2024 2023 2024 2023 Stock-based awards 16,956 15,535 16,604 15,410 Shares related to convertible senior notes 10,050 15,410 10,050 15,410 Total anti-dilutive securities 27,006 30,945 26,654 30,820

Income taxes (Tables)

Income taxes (Tables)	9 Months Ended
Income taxes (Tables)	Sep. 30, 2024
Income Tax Disclosure [Abstract]
Schedule of Components of Income Tax Expense (Benefit)	The following table provides the income tax expense (benefit) amount: Three months ended September 30, Nine months ended September 30, (dollars in thousands) 2024 2023 2024 2023 Income tax expense (benefit) $ 2,083 $ 689 $ 301,625 $ (11,562)

Commitments, contingencies an_2

Commitments, contingencies and guarantees (Tables)	9 Months Ended
Commitments, contingencies and guarantees (Tables)	Sep. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Components of Lease Expense [Text Block]	The components of net lease cost, which were primarily recorded in operating expenses, were as follows: Three months ended September 30, Nine months ended September 30, (in thousands) 2024 2023 2024 2023 Operating lease cost (1) $ 2,486 $ 2,363 $ 7,792 $ 8,557 Sublease income (722) (277) (2,094) (1,723) Right-of-use asset impairment cost — — 3,276 — Net lease cost $ 1,764 $ 2,086 $ 8,974 $ 6,834 (1) Operating lease costs include immaterial variable lease costs and amounts related to restructuring charges, which are discussed in Note 12 Restructuring charges. Supplemental cash flow information related to leases was as follows: Nine months ended September 30, (in thousands) 2024 2023 Cash paid for amounts included in the measurement of lease liabilities Operating cash flows from operating leases $ 10,371 $ 9,526 Right-of-use assets obtained in exchange for operating lease liabilities 4,801 3,047 Supplemental balance sheet information related to leases was as follows: September 30, 2024 December 31, 2023 Weighted-average remaining lease term (in years) - operating leases 3.26 3.05 Weighted-average discount rate - operating leases 6.3% 6.2%
Schedule of Maturities of Lease Liabilities [Text Block]	As of September 30, 2024, maturities of operating lease liabilities were as follows: (in thousands) September 30, 2024 2024 (remaining 3 months) $ 2,440 2025 13,750 2026 13,270 2027 2,148 2028 811 Thereafter 3,782 Total lease payments 36,201 Less: Imputed interest (3,989) Present value of lease liabilities $ 32,212

Concentrations of risk and ge_2

Concentrations of risk and geographic information (Tables)	9 Months Ended
Concentrations of risk and geographic information (Tables)	Sep. 30, 2024
Concentration Risk [Line Items]
Schedule of Accounts, Notes, Loans and Financing Receivable	The following table summarizes the Company’s accounts receivables sold, without recourse, and factoring fees paid: Three months ended September 30, Nine months ended September 30, (in thousands) 2024 2023 2024 2023 Accounts receivable sold $ 21,997 $ 32,011 $ 59,489 $ 73,050 Factoring fees 308 434 834 1,101
Schedule of Revenue by Geographic Region	Revenue by geographic region, based on ship-to locations, was as follows: Three months ended September 30, Nine months ended September 30, (in thousands) 2024 2023 2024 2023 Americas $ 109,332 $ 131,612 $ 274,648 $ 342,775 Europe, Middle East and Africa (EMEA) 84,416 83,490 200,907 196,006 Asia and Pacific (APAC) 65,150 79,197 125,036 171,258 Total revenue $ 258,898 $ 294,299 $ 600,591 $ 710,039
Accounts Receivable [Member]
Concentration Risk [Line Items]
Schedules of Customer Concentration by Risk Factor	Customers who represented 10% or more of the Company’s net accounts receivable balance were as follows: September 30, 2024 December 31, 2023 Customer A 22% 30% Customer B 10% 11%
Sales Revenue [Member]
Concentration Risk [Line Items]
Schedules of Customer Concentration by Risk Factor	Third-party customers who represented 10% or more of the Company’s total revenue were as follows: Three months ended September 30, Nine months ended September 30, 2024 2023 2024 2023 Customer A * 12% * 10% Customer B * * * 10%

Summary of business and signi_3

Summary of business and significant accounting policies (Details) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
	Nov. 20, 2023	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023	Nov. 24, 2020
Property, Plant and Equipment [Line Items]
Operating Lease, Impairment Loss		$ 0	$ 0	$ 3,276	$ 0
Contract with Customer, Liability		57,000		57,000		$ 59,100
Deferred Revenue, Revenue Recognized		11,200	12,200	50,600	50,600
Accumulated deficit		(644,416)		(644,416)		(249,296)
Product Warranty Liability [Line Items]
Gain (Loss) on Extinguishment of Debt	$ 3,100
Revenues		258,898	294,299	600,591	710,039
Deferred Revenue, Revenue Recognized		23,000	23,100
Gain (Loss) on Extinguishment of Debt	$ 3,100
Revenues		258,898	294,299	$ 600,591	710,039
Liquidity				Liquidity. As of September 30, 2024, the Company had $130.2 million in cash, cash equivalents and marketable securities and an accumulated deficit of $644.4 million. Based on the Company’s current cash balance, its cost reductions implemented to date, and working capital adjustments, the Company anticipates it will have sufficient funds to meet its strategic and working capital requirements, debt service requirements and lease payment obligations for at least twelve months from the issuance of these condensed consolidated financial statements. The Company also had $44.8 million available to draw from its 2021 Credit Agreement (as defined below) as of September 30, 2024 and its 2025 Notes are due in November 2025, which the Company has the ability to convert the balance due into stock under certain circumstances. If the Company is unable to obtain adequate debt or equity financing when it is required or on terms acceptable to the Company, the Company’s ability to grow its business, repay debt and respond to business challenges could be significantly limited. Although management believes its current cash resources are sufficient to sustain operations for one year from issuance of these condensed consolidated financial statements, the success of the Company’s operations and the global economic outlook, among other factors, could impact its business and liquidity. The Company will continue to evaluate additional measures, including cost reduction initiatives, debt or equity refinancing, and other similar arrangements. In addition, in October 2024, the Company initiated a cost reduction effort that is expected to reduce headcount by approximately 26% compared to its headcount ending Q2 2024, reduce marketing expenses in the second half of 2024 as well as 2025, and reduce other general expenses. Management considered whether there are conditions or events that raise substantial doubt about the Company’s ability to continue as a going concern and evaluated the funds necessary to maintain operations. Based on the Company’s current cash flow projections, the Company has concluded that its available cash and cash equivalents are sufficient to continue operating activities for at least twelve months following the issuance date of these condensed consolidated financial statements.
Cash and cash equivalents		$ 130,195	$ 220,984	$ 130,195	$ 220,984	$ 222,708
Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount		13%		13%
Market Capitalization Sensitivity		8%		8%
Subscription and Service Revenue
Product Warranty Liability [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax		$ 27,500		$ 79,700
Revenue from Contract with Customer, Excluding Assessed Tax		$ 27,500		$ 79,700
Subscription and Service Revenue \| Revenue from Contract with Customer Benchmark \| Product Concentration Risk
Product Warranty Liability [Line Items]
Concentration risk		10.60%		13.30%
Concentration risk		10.60%		13.30%
Convertible Senior Notes due 2025 [Member]
Property, Plant and Equipment [Line Items]
Interest rate							1.25%
Debt Instrument							$ 143,800

Business Acquisitions (Details)

Business Acquisitions (Details) - USD ($) $ in Thousands		3 Months Ended
Business Acquisitions (Details) - USD ($) $ in Thousands	Feb. 27, 2024	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2023
Business Acquisition [Line Items]
Identifiable intangible assets	$ 7,500
Goodwill	5,900	$ 152,351						$ 146,459
Allocated share-based compensation expense		$ 7,372	$ 7,791	$ 8,770	$ 10,017	$ 11,117	$ 10,314
forcite
Business Acquisition [Line Items]
Business Combination, Consideration Transferred	$ 14,000

Fair value measurements (Detail

Fair value measurements (Details) - USD ($) $ in Thousands	Nov. 20, 2023	Sep. 30, 2024	Dec. 31, 2023	Nov. 24, 2020
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash		$ 69,900	$ 69,900
Marketable securities		0	23,867
Equity Securities without Readily Determinable Fair Value, Amount		1,000	0
Repayments of Convertible Debt	$ 50,000
Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents		60,344	152,760
Marketable securities		0	23,867
Fair Value, Recurring [Member] \| Money Market Funds [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents		60,344	152,760
Fair Value, Recurring [Member] \| Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents		60,344	152,760
Marketable securities		0	0
Fair Value, Recurring [Member] \| Level 1 [Member] \| Money Market Funds [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents		60,344	152,760
Fair Value, Recurring [Member] \| Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents		0	0
Marketable securities		0	23,867
Fair Value, Recurring [Member] \| Level 2 [Member] \| Money Market Funds [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents		0	0
Convertible Senior Notes due 2025 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt Instrument				$ 143,800
Convertible Senior Notes due 2025 [Member] \| Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of convertible senior notes		82,500	82,300
Corporate Debt Securities [Member] \| Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities		0	3,978
Corporate Debt Securities [Member] \| Fair Value, Recurring [Member] \| Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities		0	0
Corporate Debt Securities [Member] \| Fair Value, Recurring [Member] \| Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities		0	3,978
Commercial Paper \| Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities		0	7,942
Commercial Paper \| Fair Value, Recurring [Member] \| Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities		0	0
Commercial Paper \| Fair Value, Recurring [Member] \| Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities		0	7,942
US Government Debt Securities [Member] \| Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities		0	3,985
US Government Debt Securities [Member] \| Fair Value, Recurring [Member] \| Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities		0	0
US Government Debt Securities [Member] \| Fair Value, Recurring [Member] \| Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities		0	3,985
US Treasury Securities \| Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities		0	7,962
US Treasury Securities \| Fair Value, Recurring [Member] \| Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities		0	0
US Treasury Securities \| Fair Value, Recurring [Member] \| Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities		$ 0	$ 7,962

Condensed consolidated financ_3

Condensed consolidated financial statement details - Cash, Cash Equivalents and Marketable Securities (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2023
Cash and Cash Equivalents [Line Items]
Cash	$ 69,900	$ 69,900
Cash and cash equivalents	$ 130,195	$ 222,708	$ 220,984

Condensed consolidated financ_4

Condensed consolidated financial statement details - Inventory (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Components	$ 30,971	$ 20,311
Finished goods	124,288	85,955
Total inventory	$ 155,259	$ 106,266

Condensed consolidated financ_5

Condensed consolidated financial statement details - Property and Equipment, Net (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Property, Plant and Equipment [Line Items]
Gross property and equipment	$ 87,780	$ 88,126
Less: Accumulated depreciation and amortization	(78,982)	(79,440)
Property and equipment, net	8,798	8,686
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Gross property and equipment	24,000	23,818
Production, engineering and other equipment [Member]
Property, Plant and Equipment [Line Items]
Gross property and equipment	38,252	38,574
Tooling [Member]
Property, Plant and Equipment [Line Items]
Gross property and equipment	6,361	5,678
Computers and software [Member]
Property, Plant and Equipment [Line Items]
Gross property and equipment	13,820	13,896
Furniture and office equipment [Member]
Property, Plant and Equipment [Line Items]
Gross property and equipment	3,790	4,575
Tradeshow Equipment and other [Member]
Property, Plant and Equipment [Line Items]
Gross property and equipment	1,452	1,502
Construction in Progress [Member]
Property, Plant and Equipment [Line Items]
Gross property and equipment	$ 105	$ 83

Condensed consolidated financ_6

Condensed consolidated financial statement details - Intangible Assets and Goodwill (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Feb. 27, 2024	Dec. 31, 2023
Finite-Lived Intangible Assets, Net [Abstract]
Finite-Lived Intangible Assets, Gross	$ 58,566		$ 58,566			$ 51,066
Finite-Lived Intangible Assets, Accumulated Amortization	(52,160)		(52,160)			(51,066)
Finite-Lived Intangible Assets, Net, Total	6,406		6,406			0
Intangible Assets, Gross (Excluding Goodwill)	58,581		58,581			51,081
Intangible assets, net	6,421		6,421			15
Indefinite-lived Intangible Assets [Roll Forward]
Amortization of intangible assets	500	$ 0	1,100	$ 0
Goodwill	152,351		152,351		$ 5,900	146,459
Indefinite-Lived Trademarks	15		15			15
Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Net (Excluding Goodwill)	6,421		6,421			$ 15
Amortization of intangible assets	$ 500	$ 0	$ 1,100	$ 0

Condensed consolidated financ_7

Condensed consolidated financial statement details - Future Amortization (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Finite-Lived Intangible Asset, Expected Amortization, Year Two	$ 1,875
Finite-Lived Intangible Assets, Net, Total	6,406	$ 0
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Expected Amortization, Year Two	1,875
Finite-Lived Intangible Assets, Amortization Expense, Year Three	1,875
Finite-Lived Intangible Asset, Expected Amortization, Year Four	1,875
Finite-Lived Intangible Asset, Expected Amortization, Year Five	313
2020	468
Finite-Lived Intangible Assets, Net	6,406	$ 0
Finite-Lived Intangible Asset, Expected Amortization, Year One	$ 1,875

Condensed consolidated financ_8

Condensed consolidated financial statement details - Goodwill (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Feb. 27, 2024	Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Goodwill	$ 152,351	$ 5,900	$ 146,459

Condensed consolidated financ_9

Condensed consolidated financial statement details - Other Assets (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
POP Displays	$ 14,853		$ 14,853		$ 6,254
Deposits and other	8,122		8,122		8,233
Other long-term assets	30,137		30,137		311,486
Amortization of intangible assets	500	$ 0	1,100	$ 0
Intangible Assets, Net (Excluding Goodwill)	6,421		6,421		15
Deferred Income Tax Assets, Net	$ 741		$ 741		$ 296,984

Condensed consolidated finan_10

Condensed consolidated financial statement details - Product Warranty (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Beginning balances	$ 6,520	$ 7,304	$ 8,759	$ 8,319
Charged to cost of revenue	4,234	6,284	8,573	14,758
Settlements of warranty claims	(3,385)	(5,392)	(9,963)	(14,881)
Ending balances	7,369	$ 8,196	7,369	$ 8,196
Product Warranty Accrual, Noncurrent	600		600		$ 500
Product Warranty Accrual, Current	$ 6,801		$ 6,801		$ 8,270

Condensed consolidated finan_11

Condensed consolidated financial statement details - Accrued Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Product Warranty Accrual, Current	$ 6,801	$ 8,270
Employee related liabilities	5,846	18,969
Accrued sales incentives	53,668	42,752
Other Accounts Payable and Accrued Liabilities	30,792	21,214
Customer Refund Liability, Current	6,102	6,389
Customer deposits	2,458	1,933
Purchase Commitment, Remaining Minimum Amount Committed	1,619	899
Inventory received	8,944	1,745
Other	8,069	7,878
Accrued expenses and other current liabilities	$ 124,299	$ 110,049

Financing Arrangements (Details

Financing Arrangements (Details)				3 Months Ended		9 Months Ended
Financing Arrangements (Details)	Nov. 20, 2023 USD ($)	Jan. 22, 2021 USD ($)	Nov. 24, 2020 USD ($) $ / shares	Sep. 30, 2024 USD ($)	Sep. 30, 2023 USD ($)	Sep. 30, 2024 USD ($)	Sep. 30, 2023 USD ($)	Dec. 31, 2023 USD ($)
Line of Credit Facility [Line Items]
Long-term debt				$ 93,053,000		$ 93,053,000		$ 92,615,000
Operating Lease, Impairment Loss				0	$ 0	3,276,000	$ 0
Debt Instrument, Covenant Compliance, Asset Coverage Ratio		1.50
Adjustments to Additional Paid in Capital, Capped Call Option, Issuance Costs			$ 10,200,000
Option Indexed To Issuers Equity, cap price			12.0925
Gain (Loss) on Extinguishment of Debt	$ 3,100,000
Debt Instrument, Repurchase Amount	46,300,000
Debt Instrument, Repurchased Face Amount	$ 49,400,000
Letters of Credit Outstanding, Amount				5,200,000		5,200,000
Convertible Senior Notes due 2025 [Member] \| Private Placement [Member]
Line of Credit Facility [Line Items]
Debt Instrument			125,000,000
2021 Credit Facility [Member]
Line of Credit Facility [Line Items]
Credit agreement, current borrowing capacity		$ 50,000,000
Minimum Fixed Charge Coverage Ratio, minimum balance		10,000,000
Line of Credit Facility, Unused Capacity, Minimum Liquidity Requirement, Amount		55,000,000
Line of Credit Facility, Unused Capacity, Qualified Cash		$ 40,000,000
Line of Credit Facility, Remaining Borrowing Capacity				44,800,000		44,800,000
Line of Credit Facility, Remaining Borrowing Capacity				44,800,000		44,800,000
Convertible Senior Notes due 2025 [Member]
Line of Credit Facility [Line Items]
Debt Instrument			$ 143,800,000
Interest rate			1.25%
Debt Instrument, Convertible, Conversion Ratio			107.1984
Convertible Debt Principal Amount Conversion			$ 1,000	$ 93,800,000		$ 93,800,000		$ 93,800,000
Debt Instrument, Convertible, Conversion Price \| $ / shares			$ 9.3285
Effective rate				1.40%		1.40%		2.80%
Percentage of conversion price of notes				130%
Percentage of trading price of notes				98%
Long-term debt				$ 93,100,000		$ 93,100,000		$ 92,600,000
Interest Expense, Debt				300,000	400,000	900,000	1,300,000
Amortization of Debt Issuance Costs				200,000	$ 200,000	500,000	$ 700,000
Convertible Senior Notes due 2025 [Member] \| Long-term Debt [Member]
Line of Credit Facility [Line Items]
Debt Issuance Costs, Net				$ 700,000		$ 700,000		$ 1,200,000
Convertible Senior Notes due 2025 [Member] \| Over-Allotment Option [Member]
Line of Credit Facility [Line Items]
Debt Instrument			$ 18,800,000
Base Rate [Member] \| Minimum [Member] \| 2021 Credit Facility [Member]
Line of Credit Facility [Line Items]
Basis Spread on Variable Rate		0.50%
Base Rate [Member] \| Maximum [Member] \| 2021 Credit Facility [Member]
Line of Credit Facility [Line Items]
Basis Spread on Variable Rate		1%
Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate \| Minimum [Member] \| 2021 Credit Facility [Member]
Line of Credit Facility [Line Items]
Basis Spread on Variable Rate		1.50%
Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate \| Maximum [Member] \| 2021 Credit Facility [Member]
Line of Credit Facility [Line Items]
Basis Spread on Variable Rate		2%

Stockholders' equity (Details)

Stockholders' equity (Details) - USD ($)	3 Months Ended				9 Months Ended
Stockholders' equity (Details) - USD ($)	Sep. 30, 2024	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2024	Sep. 30, 2023	Jun. 30, 2024	Mar. 31, 2024	Dec. 31, 2023	Feb. 09, 2023	Dec. 31, 2022	Jan. 27, 2022
Class of Stock [Line Items]
Stock options outstanding (shares)	2,327,000				2,327,000				2,684,000
Stockholders' Equity Attributable to Parent	$ 183,943,000	$ 559,080,000	$ 563,479,000	$ 585,150,000	$ 183,943,000	$ 559,080,000	$ 184,679,000	$ 224,912,000	$ 555,846,000		$ 611,559,000
Stock Repurchase Program, Authorized Amount										$ 40		$ 100
Stock Repurchase Program, Remaining Authorized Repurchase Amount	$ 60,400,000				$ 60,400,000
Treasury Stock, Shares, Acquired	0	2,605			0	7,101
Treasury Stock Acquired, Average Cost Per Share	$ 0	$ 3.84			$ 0	$ 4.22
Stock Repurchased During Period, Value	$ 0	$ 10,000,000	15,000,000	5,000,000	$ 0	$ 30,000,000
Treasury Stock, Value, Acquired, Cost Method		10,000,000	15,000,000	5,000,000
Treasury Stock, Common
Class of Stock [Line Items]
Stockholders' Equity Attributable to Parent	$ (193,231,000)	$ (183,231,000)	$ (173,231,000)	$ (158,231,000)	$ (193,231,000)	$ (183,231,000)	$ (193,231,000)	$ (193,231,000)	$ (193,231,000)		$ (153,231,000)
Common Class A [Member]
Class of Stock [Line Items]
Common stock authorized (shares)	500,000,000				500,000,000				500,000,000
Common stock outstanding (shares)	128,502,000				128,502,000				123,638,000
Common Stock, Voting Rights, Number					1
Common Stock, Shares, Issued	128,502,000				128,502,000				123,638,000
Common Class B [Member]
Class of Stock [Line Items]
Common stock authorized (shares)	150,000,000				150,000,000				150,000,000
Common stock outstanding (shares)	26,259,000				26,259,000				26,259,000
Common Stock, Voting Rights, Number					10
Common Stock, Shares, Issued	26,259,000				26,259,000				26,259,000
Restricted Stock Units (RSUs) [Member]
Class of Stock [Line Items]
Restricted stock units outstanding (shares)	12,058,000				12,058,000				11,494,000
Performance Shares [Member]
Class of Stock [Line Items]
Restricted stock units outstanding (shares)	1,894,000				1,894,000				829,000

Employee benefit plans - Narrat

Employee benefit plans - Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended						9 Months Ended
	Sep. 30, 2024	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2024	Sep. 30, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated share-based compensation expense		$ 7,372	$ 7,791	$ 8,770	$ 10,017	$ 11,117	$ 10,314
ESPP weighted average purchase price of shares purchased (usd per share)								$ 1.56	$ 4.10
Unearned stock-based compensation, expected recognition period	2 years 3 months 21 days
Share-based Payment Arrangement, Expense, Tax Benefit					$ 2,300			$ 0	$ 7,100
Stock Issued During Period, Shares, Employee Stock Purchase Plans								1,400,000	900,000
Stock Repurchased During Period, Shares					2,605,000	3,606,000	890,000
Treasury Stock Acquired, Average Cost Per Share		$ 0			$ 3.84			$ 0	$ 4.22
Stock Repurchased During Period, Value		$ 0			$ 10,000	$ 15,000	$ 5,000	$ 0	$ 30,000
RSUs [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares granted (shares)								6,616,000
Weighted average price of shares granted (usd per share)								$ 1.91
Performance Shares [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares granted (shares)								1,531,000
Weighted average price of shares granted (usd per share)								$ 1.70
Employee Stock Purchase Plan Shares [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Purchase Price of Common Stock, Percent								85%
Stock Options, ESPP and Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unearned stock-based compensation costs	$ 39,000	$ 39,000						$ 39,000
2024 Equity Incentive Plans \| Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expiration Period								10 years
2024 Equity Incentive Plans \| Performance Shares [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award Vesting Period								3 years
2024 Equity Incentive Plans \| Minimum [Member] \| Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award Vesting Period								1 year
2024 Equity Incentive Plans \| Minimum [Member] \| RSUs [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award Vesting Period								2 years
2024 Equity Incentive Plans \| Maximum [Member] \| Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award Vesting Period								4 years
2024 Equity Incentive Plans \| Maximum [Member] \| RSUs [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award Vesting Period								4 years

Employee benefit plans - Stock

Employee benefit plans - Stock Option Activity (Details) - USD ($) $ / shares in Units, shares in Thousands		9 Months Ended
	Dec. 31, 2023	Sep. 30, 2024
Shares (in thousands)
Outstanding at beginning of period (shares)		2,684
Granted (shares)		0
Exercised (shares)		0
Forfeited/Cancelled (shares)		(357)
Outstanding at end of period (shares)	2,684	2,327
Weighted-average exercise price
Outstanding at beginning of period (in dollars per share)		$ 8.43
Granted (usd per share)		0
Exercised (usd per share)		0
Outstanding at end of period (in dollars per share)	$ 8.43	$ 7.43
Aggregate intrinsic value (in thousands)	$ 0	$ 0
Vested and Expected to Vest (shares)		2,327
Vested and Expected to Vest - Weighted Average Exercise Price (in dollars per share)		$ 7.43
Vested and Expected to Vest- Weighted Average Remaining Contractual Term		4 years 10 months 2 days
Vested and Expected to Vest - Aggregate Intrinsic Value		$ 0
Exercisable (shares)		2,015
Exercisable - Weighted average exercise price (in dollars per share)		$ 7.75
Exercisable - Weighted Average Remaining Contractual Term		4 years 3 months 14 days
Exercisable - Aggregate intrinsic value		$ 0
Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price		$ 14.96
Weighted Average Remaining Contractual Term (in years)	5 years 29 days	4 years 10 months 2 days

Employee benefit plans - Restri

Employee benefit plans - Restricted Stock Units Activity (Details) shares in Thousands	9 Months Ended
	Sep. 30, 2024 $ / shares shares
RSUs [Member]
Shares (in thousands)
Non-vested shares at beginning of period (shares) \| shares	11,494
Granted (shares) \| shares	6,616
Vested (shares) \| shares	(4,481)
Forfeited (shares) \| shares	(1,571)
Non-vested shares at end of period (shares) \| shares	12,058
Weighted-average grant date fair value
Non-vested shares at beginning of period (in dollars per share) \| $ / shares	$ 5.94
Weighted average price of shares granted (usd per share) \| $ / shares	1.91
Weighted average price of shares vested (usd per share) \| $ / shares	6.02
Weighted average price of shares forfeited (usd per share) \| $ / shares	4.72
Non-vested shares at end of period (in dollars per share) \| $ / shares	$ 3.86
Performance Shares [Member]
Shares (in thousands)
Non-vested shares at beginning of period (shares) \| shares	829
Granted (shares) \| shares	1,531
Vested (shares) \| shares	(454)
Forfeited (shares) \| shares	(12)
Non-vested shares at end of period (shares) \| shares	1,894
Weighted-average grant date fair value
Non-vested shares at beginning of period (in dollars per share) \| $ / shares	$ 6.40
Weighted average price of shares granted (usd per share) \| $ / shares	1.70
Weighted average price of shares vested (usd per share) \| $ / shares	6.56
Weighted average price of shares forfeited (usd per share) \| $ / shares	5.79
Non-vested shares at end of period (in dollars per share) \| $ / shares	$ 2.57

Employee benefit plans - Alloca

Employee benefit plans - Allocation of Stock-based Compensation Expense (Details) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense		$ 7,372	$ 10,017	$ 23,933	$ 31,448
Share-based Payment Arrangement, Expense, Tax Benefit			2,300	0	7,100
Unearned stock-based compensation, expected recognition period	2 years 3 months 21 days
Cost of Revenue [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense		349	500	1,103	1,496
Research and Development [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense		3,669	4,713	11,950	14,381
Selling and Marketing Expense [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense		1,603	2,125	4,892	6,662
General and Administrative [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense		$ 1,751	$ 2,679	$ 5,988	$ 8,909

Employee benefit plans Performa

Employee benefit plans Performance Stock Units activity (Details) - $ / shares shares in Thousands	9 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Performance Shares [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock units outstanding (shares)	1,894	829
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value	$ 2.57	$ 6.40
Granted (shares)	1,531
Weighted average price of shares granted (usd per share)	$ 1.70
Vested (shares)	(454)
Weighted average price of shares vested (usd per share)	$ 6.56
Forfeited (shares)	(12)
Weighted average price of shares forfeited (usd per share)	$ 5.79
Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock units outstanding (shares)	12,058	11,494
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value	$ 3.86	$ 5.94
Granted (shares)	6,616
Weighted average price of shares granted (usd per share)	$ 1.91
Vested (shares)	(4,481)
Weighted average price of shares vested (usd per share)	$ 6.02
Forfeited (shares)	(1,571)
Weighted average price of shares forfeited (usd per share)	$ 4.72

Net loss per share Additional I

Net loss per share Additional Information (Details)	9 Months Ended
Net loss per share Additional Information (Details)	Sep. 30, 2024 shares	Nov. 24, 2020 USD ($) $ / shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Conversion of Stock maxium percent of outstanding shares in class of total outstanding shares	10%
Option Indexed To Issuers Equity, cap price \| $		$ 12.0925
Conversion of Stock maxium percent of outstanding shares in class of total outstanding shares	10%
Common Class A [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Common Stock, Voting Rights, Number	1
Conversion of Stock, Shares Issued	1
Common Class B [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Common Stock, Voting Rights, Number	10
Convertible Senior Notes due 2025 [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Debt Instrument \| $		$ 143,800,000
Interest rate		1.25%
Debt Instrument, Convertible, Conversion Price \| $ / shares		$ 9.3285

Net loss per share - Basic and

Net loss per share - Basic and Diluted Net Income per Share Attributable to Common Stockholders (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2024	Sep. 30, 2023
Numerator:
Net loss	$ (8,211)	$ (47,821)	$ (339,088)	$ (3,684)	$ (17,212)	$ (29,869)	$ (395,120)	$ (50,765)
Denominator:
Weighted Average Number of Shares Outstanding, Basic	153,741			152,409			152,449	154,113
Earnings Per Share, Diluted	$ (0.05)			$ (0.02)			$ (2.59)	$ (0.33)
Weighted Average Number of Shares Outstanding, Diluted	153,741			152,409			152,449	154,113

Net loss per share - Antidiluti

Net loss per share - Antidilutive Securities Excluded from Computation of Net Income per Share (Details) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Earnings Per Share [Abstract]
Antidilutive securities excluded from computation of earnings per share (shares)	27,006	30,945	26,654	30,820
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (shares)	27,006	30,945	26,654	30,820
Convertible Debt Securities
Earnings Per Share [Abstract]
Antidilutive securities excluded from computation of earnings per share (shares)	10,050	15,410	10,050	15,410
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (shares)	10,050	15,410	10,050	15,410
Share-based Payment Arrangement
Earnings Per Share [Abstract]
Antidilutive securities excluded from computation of earnings per share (shares)	16,956	15,535	16,604	15,410
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (shares)	16,956	15,535	16,604	15,410

Income taxes - Income Tax Expen

Income taxes - Income Tax Expense (Details) - USD ($)			3 Months Ended		9 Months Ended
Income taxes - Income Tax Expense (Details) - USD ($)	Sep. 30, 2024	Mar. 31, 2024	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Income Tax Disclosure [Abstract]
Income tax (benefit) expense			$ 2,083,000	$ 689,000	$ 301,625,000	$ (11,562,000)
Current Foreign Tax Expense (Benefit)			2,100,000	1,000,000	5,000,000	14,400,000
Other Tax Expense (Benefit)			100,000	100,000	500,000	100,000
Income Tax Effects Allocated Directly to Equity, Other			1,900,000	$ 1,700,000	4,900,000	$ 2,400,000
Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions	$ 3,900,000
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount		$ 294,900,000	$ (1,600,000)		$ 293,400,000
Minimum Effective Tax	1,500%		1,500%		1,500%

Income taxes - Narrative (Detai

Income taxes - Narrative (Details) - USD ($)			3 Months Ended		9 Months Ended
Income taxes - Narrative (Details) - USD ($)	Sep. 30, 2024	Mar. 31, 2024	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Operating Loss Carryforwards [Line Items]
Other Tax Expense (Benefit)			$ 100,000	$ 100,000	$ 500,000	$ 100,000
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount		$ 294,900,000	(1,600,000)		293,400,000
Income tax (benefit) expense			2,083,000	689,000	301,625,000	(11,562,000)
Loss before income taxes			(6,128,000)	(2,995,000)	(93,495,000)	(62,327,000)
Income tax (benefit) expense			2,083,000	689,000	301,625,000	(11,562,000)
Loss before income taxes			(6,128,000)	(2,995,000)	(93,495,000)	(62,327,000)
Current Foreign Tax Expense (Benefit)			2,100,000	1,000,000	5,000,000	14,400,000
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount		$ 294,900,000	(1,600,000)		293,400,000
Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions	$ (3,900,000)
Unrecognized Tax Benefits	29,800,000		29,800,000		29,800,000		$ 25,800,000
Unrecognized Tax Benefits that Would Impact Effective Tax Rate	$ 14,000,000		14,000,000		14,000,000
Income Tax Effects Allocated Directly to Equity, Other			1,900,000	1,700,000	4,900,000	2,400,000
Restructuring adjustments			$ 300,000	$ 100,000	$ 1,300,000	$ 300,000

Income taxes - Deferred Tax Ass

Income taxes - Deferred Tax Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Deferred tax assets:
Deferred Tax Assets, Net, Total	$ 741	$ 296,984

Income taxes - Reconciliation (

Income taxes - Reconciliation (Details) - USD ($)	3 Months Ended		9 Months Ended
Income taxes - Reconciliation (Details) - USD ($)	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Income Tax Disclosure [Abstract]
Income tax (benefit) expense	$ 2,083,000	$ 689,000	$ 301,625,000	$ (11,562,000)

Commitments, contingencies an_3

Commitments, contingencies and guarantees (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Long-term Purchase Commitment [Line Items]
Operating Lease, Cost	$ 2,486	$ 2,363	$ 7,792	$ 8,557
Operating Lease, Payments			10,371	9,526
Finance Lease, Liability, to be Paid, Year One	2,440		2,440
Finance Lease, Liability, to be Paid, Year Two	13,750		13,750
Finance Lease, Liability, to be Paid, Year Three	13,270		13,270
Finance Lease, Liability, to be Paid, Year Four	2,148		2,148
Finance Lease, Liability, to be Paid, Year Five	811		811
Lessee, Operating Lease, Liability, Payments, Due after Year Five	3,782		3,782
Lessee, Operating Lease, Liability, Payments, Due	(36,201)		(36,201)
us-gaap_Lessee Operating Lease Liability Undiscounted Excess Amount	(3,989)		(3,989)
Operating Lease, Liability	$ 32,212		32,212
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability			$ 4,801	3,047
Operating Lease, Weighted Average Remaining Lease Term	3 years 3 months 3 days		3 years 3 months 3 days		3 years 18 days
Operating Lease, Weighted Average Discount Rate, Percent	6.30%		6.30%		6.20%
Sublease Income	$ (722)	(277)	$ (2,094)	(1,723)
Operating Lease, Impairment Loss	0	0	3,276	0
Lease, Cost	1,764	$ 2,086	8,974	$ 6,834
Other Commitments [Line Items]
Other Commitment	$ 224,400		$ 224,400

Concentrations of risk and ge_3

Concentrations of risk and geographic information - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Revenue, Major Customer [Line Items]
Revenues	$ 258,898	$ 294,299	$ 600,591	$ 710,039
United States [Member]
Revenue, Major Customer [Line Items]
Revenues	79,600	$ 100,900	204,200	$ 283,000
Outside the United States [Member]
Revenue, Major Customer [Line Items]
Assets, Noncurrent	3,200		3,200		$ 1,600
Assets, Noncurrent	$ 3,200		$ 3,200		$ 1,600

Concentrations of risk and ge_4

Concentrations of risk and geographic information - Schedule of Customer Concentration by Risk Factor (Details) - USD ($) $ in Thousands			3 Months Ended		9 Months Ended
	Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Concentration Risk [Line Items]
Accounts receivable sold			$ 21,997	$ 32,011	$ 59,489	$ 73,050
Factoring fees			$ 308	$ 434	$ 834	$ 1,101
Customer Concentration Risk [Member] \| Accounts Receivable [Member] \| Customer A [Member]
Concentration Risk [Line Items]
Concentration risk	22%	30%
Customer Concentration Risk [Member] \| Accounts Receivable [Member] \| Customer B [Member]
Concentration Risk [Line Items]
Concentration risk	10%	11%
Customer Concentration Risk [Member] \| Sales Revenue [Member] \| Customer A [Member]
Concentration Risk [Line Items]
Concentration risk				12%		10%
Customer Concentration Risk [Member] \| Sales Revenue [Member] \| Customer B [Member]
Concentration Risk [Line Items]
Concentration risk						10%

Concentrations of risk and ge_5

Concentrations of risk and geographic information - Schedule of Revenue by Geographic Segment (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Segment Reporting Information [Line Items]
Revenues	$ 258,898	$ 294,299	$ 600,591	$ 710,039
United States [Member]
Segment Reporting Information [Line Items]
Revenues	79,600	100,900	204,200	283,000
Americas [Member]
Segment Reporting Information [Line Items]
Revenues	109,332	131,612	274,648	342,775
Europe, Middle East and Africa [Member]
Segment Reporting Information [Line Items]
Revenues	84,416	83,490	200,907	196,006
Asia and Pacific Area Countries [Member]
Segment Reporting Information [Line Items]
Revenues	$ 65,150	$ 79,197	$ 125,036	$ 171,258

Restructuring charges - Restruc

Restructuring charges - Restructuring Costs (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Costs			12. Restructuring charges Restructuring charges for each period were as follows: Three months ended September 30, Nine months ended September 30, (in thousands) 2024 2023 2024 2023 Cost of revenue $ 13 $ — $ 178 $ (183) Research and development 825 — 3,420 10 Sales and marketing 397 — 1,867 6 General and administrative 147 — 1,177 3 Total restructuring charges $ 1,382 $ — $ 6,642 $ (164)
Operating Lease, Impairment Loss	$ 0	$ 0	$ 3,276,000	$ 0
Restructuring charges	1,382,000	0	6,642,000	(164,000)
Cost of Revenue [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring charges	13,000	0	178,000	(183,000)
Research and Development [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring charges	825,000	0	3,420,000	10,000
Selling and Marketing Expense [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring charges	397,000	0	1,867,000	6,000
General and Administrative [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring charges	147,000	$ 0	1,177,000	$ 3,000
First quarter 2024 restructuring
Restructuring Cost and Reserve [Line Items]
Restructuring charges			5,808,000
Restructuring Reserve	59,000		59,000		$ 0
Severance Costs			2,257,000
Cash paid			(2,251,000)
Restructuring Reserve, Settled without Cash			(3,498,000)
First quarter 2024 restructuring \| Employee Severance [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve	59,000		59,000		0
Cash paid			(1,976,000)
Restructuring Reserve, Settled without Cash			(222,000)
First quarter 2024 restructuring \| Other Restructuring [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve	0		0		0
Cash paid			(275,000)
Restructuring Reserve, Settled without Cash			0
Restructuring Costs and Asset Impairment Charges			275,000
First quarter 2024 restructuring \| ROU Asset Impairment
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve	0		0		0
Restructuring Reserve, Settled without Cash			(3,276,000)
First quarter 2024 restructuring \| Cease of use impairment charge
Restructuring Cost and Reserve [Line Items]
Cash paid			0
Restructuring Costs and Asset Impairment Charges			3,276,000
First quarter 2024 restructuring \| Office space charges
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Expected Cost	1,900,000		1,900,000
Restructuring and Related Cost, Expected Cost	1,900,000		1,900,000
Third quarter 2024 restructuring
Restructuring Cost and Reserve [Line Items]
Restructuring charges			1,104,000
Restructuring Reserve	360,000		360,000		0
Severance Costs	1,100,000		1,104,000
Cash paid			(744,000)
Restructuring Reserve, Settled without Cash			0
Third quarter 2024 restructuring \| Employee Severance [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve	360,000		360,000		$ 0
Cash paid			(744,000)
Restructuring Reserve, Settled without Cash			0
Restructuring and Related Cost, Expected Cost	9		9
Restructuring and Related Cost, Expected Cost	9		9
Third quarter 2024 restructuring \| Contract Termination
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Expected Cost	8		8
Restructuring and Related Cost, Expected Cost	$ 8		$ 8

Restructuring charges - Narrati

Restructuring charges - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$ 1,382	$ 0	$ 6,642	$ (164)
Operating Lease, Impairment Loss	$ 0	$ 0	3,276	$ 0
First quarter 2024 restructuring
Restructuring Cost and Reserve [Line Items]
Expected percent of positions eliminated	4%
Severance Costs			2,257
First quarter 2024 restructuring \| Other Restructuring [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Costs and Asset Impairment Charges			275
Third quarter 2024 restructuring
Restructuring Cost and Reserve [Line Items]
Expected percent of positions eliminated	15%
Severance Costs	$ 1,100		$ 1,104

Restructuring charges - Restr_2

Restructuring charges - Restructuring Liability (Details) - First quarter 2024 restructuring $ in Thousands	9 Months Ended
	Sep. 30, 2024 USD ($)
Restructuring Cost and Reserve [Line Items]
Severance Costs	$ 2,257
Restructuring Reserve [Roll Forward]
Restructuring liability as of October 1, 2016	0
Restructuring charges	(5,808)
Cash paid	(2,251)
Non-cash settlements	(3,498)
Restructuring liability as of December 31, 2017	59
Employee Severance [Member]
Restructuring Reserve [Roll Forward]
Restructuring liability as of October 1, 2016	0
Cash paid	(1,976)
Non-cash settlements	(222)
Restructuring liability as of December 31, 2017	59
Other Restructuring [Member]
Restructuring Reserve [Roll Forward]
Restructuring liability as of October 1, 2016	0
Cash paid	(275)
Non-cash settlements	0
Restructuring liability as of December 31, 2017	0
Restructuring Costs and Asset Impairment Charges	275
Cease of use impairment charge
Restructuring Reserve [Roll Forward]
Cash paid	0
Restructuring Costs and Asset Impairment Charges	3,276
ROU Asset Impairment
Restructuring Reserve [Roll Forward]
Restructuring liability as of October 1, 2016	0
Non-cash settlements	(3,276)
Restructuring liability as of December 31, 2017	$ 0

Subsequent Events (Details)

Subsequent Events (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
Subsequent Events (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Subsequent Event [Line Items]
Restructuring charges	$ 1,382	$ 0	$ 6,642	$ (164)
Sublease Income	$ 722	$ 277	$ 2,094	$ 1,723
Operating Lease, Weighted Average Discount Rate, Percent	6.30%		6.30%		6.20%

Valuation and Qualifying Acco_2

Valuation and Qualifying Accounts (Details) - USD ($)	9 Months Ended
Valuation and Qualifying Accounts (Details) - USD ($)	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Allowance for Doubtful Accounts Receivable [Member]
SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]
SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount				$ 450,000	$ 390,000	$ 700,000	$ 492,000
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Charges to Expense	$ 67,000	$ (294,000)	$ 393,000
SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction	$ (7,000)	$ (16,000)	(185,000)
SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]
SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]
SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount						$ 0	$ 287,276,000
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Charges to Expense			(284,551,000)
Charges to Revenue			0
SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction			$ (2,725,000)